<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Hepatorenal syndrome - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Hepatorenal_syndrome" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Hepatorenal_syndrome" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Hepatorenal_syndrome" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Hepatorenal_syndrome","wgTitle":"Hepatorenal syndrome","wgCurRevisionId":649122316,"wgRevisionId":649122316,"wgArticleId":2204330,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","Use dmy dates from April 2014","Articles that use a Medicine navs subtemplate","Featured articles","Diseases of liver","Syndromes"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Hepatorenal_syndrome","wgRelevantArticleId":2204330,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Cirrhosis_high_mag.jpg/100px-Cirrhosis_high_mag.jpg","wgULSAcceptLanguageList":["en-us"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q247131"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Hepatorenal_syndrome skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
<div id="mw-indicator-featured-star" class="mw-indicator"><a href="/wiki/Wikipedia:Featured_articles" title="This is a featured article. Click here for more information."><img alt="This is a featured article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/e/e7/Cscr-featured.svg/20px-Cscr-featured.svg.png" width="20" height="19" srcset="//upload.wikimedia.org/wikipedia/en/thumb/e/e7/Cscr-featured.svg/30px-Cscr-featured.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/e/e7/Cscr-featured.svg/40px-Cscr-featured.svg.png 2x" data-file-width="462" data-file-height="438" /></a></div>
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Hepatorenal syndrome</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Hepatorenal syndrome</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><i>Classification and external resources</i></td>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Cirrhosis_high_mag.jpg" class="image"><img alt="Photomicrograph of liver section stained in red, blue, and purple. Large amounts of fibrosis, stained blue, surround the red stained nodules." src="//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Cirrhosis_high_mag.jpg/220px-Cirrhosis_high_mag.jpg" width="220" height="147" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/94/Cirrhosis_high_mag.jpg/330px-Cirrhosis_high_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/94/Cirrhosis_high_mag.jpg/440px-Cirrhosis_high_mag.jpg 2x" data-file-width="4272" data-file-height="2848" /></a>
<div>Liver <a href="/wiki/Pathology" title="Pathology">pathology</a> is altered in HRS while kidney <a href="/wiki/Histology" title="Histology">histology</a> is normal. The upper image is a <a href="/wiki/Trichrome_stain" title="Trichrome stain">trichrome stain</a> of <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a> of the liver, the most common cause of HRS. The lower image is a <a href="/wiki/PAS_stain" title="PAS stain" class="mw-redirect">PAS stain</a> of normal kidney histology.</div>
</td>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Glomerulus_pas.JPG" class="image"><img alt="Photomicrograph of kidney section with cells stained in purple." src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Glomerulus_pas.JPG/220px-Glomerulus_pas.JPG" width="220" height="165" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Glomerulus_pas.JPG/330px-Glomerulus_pas.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Glomerulus_pas.JPG/440px-Glomerulus_pas.JPG 2x" data-file-width="600" data-file-height="450" /></a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-10_codes" title="List of ICD-10 codes" class="mw-redirect">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/K76.7">K76.7</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=572.4">572.4</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb5810.htm">5810</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000489">000489</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic1001.htm#">med/1001</a> <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/907429-overview">article/907429</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D006530">D006530</a></td>
</tr>
</table>
<p><b>Hepatorenal syndrome</b> (often abbreviated <b>HRS</b>) is a life-threatening medical condition that consists of <a href="/wiki/Acute_renal_failure" title="Acute renal failure" class="mw-redirect">rapid deterioration in kidney function</a> in individuals with <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a> or <a href="/wiki/Fulminant" title="Fulminant">fulminant</a> <a href="/wiki/Liver_failure" title="Liver failure">liver failure</a>. HRS is usually fatal unless a <a href="/wiki/Liver_transplantation" title="Liver transplantation">liver transplant</a> is performed, although various treatments, such as <a href="/wiki/Dialysis" title="Dialysis">dialysis</a>, can prevent advancement of the condition.</p>
<p>HRS can affect individuals with cirrhosis (regardless of cause), severe <a href="/wiki/Alcoholic_hepatitis" title="Alcoholic hepatitis">alcoholic hepatitis</a>, or fulminant liver failure, and usually occurs when liver function deteriorates rapidly because of an acute insult such as an infection, <a href="/wiki/Upper_gastrointestinal_hemorrhage" title="Upper gastrointestinal hemorrhage" class="mw-redirect">bleeding in the gastrointestinal tract</a>, or overuse of <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> medications. HRS is a relatively common complication of cirrhosis, occurring in 18% of cirrhotics within one year of their diagnosis, and in 39% of cirrhotics within five years of their diagnosis. Deteriorating <a href="/wiki/Liver" title="Liver">liver</a> function is believed to cause changes in the <a href="/wiki/Splanchnic_circulation" title="Splanchnic circulation" class="mw-redirect">circulation that supplies the intestines</a>, altering <a href="/wiki/Hemodynamics" title="Hemodynamics">blood flow</a> and blood vessel tone in the <a href="/wiki/Kidney" title="Kidney">kidneys</a>. The kidney failure of HRS is a consequence of these changes in blood flow, rather than direct damage to the kidney. The diagnosis of hepatorenal syndrome is based on laboratory tests of individuals susceptible to the condition. Two forms of hepatorenal syndrome have been defined: Type 1 HRS entails a rapidly progressive decline in kidney function, while type 2 HRS is associated with <a href="/wiki/Ascites" title="Ascites">ascites</a> (fluid accumulation in the abdomen) that does not improve with standard <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> medications.</p>
<p>The risk of death in hepatorenal syndrome is very high; the mortality of individuals with type 1 HRS is over 50% over the short term, as determined by historical <a href="/wiki/Case_series" title="Case series">case series</a>. The only long-term treatment option for the condition is liver transplantation. While awaiting transplantation, people with HRS often receive other treatments that improve the abnormalities in blood vessel tone, including supportive care with medications, or the insertion of a <a href="/wiki/Transjugular_intrahepatic_portosystemic_shunt" title="Transjugular intrahepatic portosystemic shunt">transjugular intrahepatic portosystemic shunt</a> (TIPS), which is a small shunt placed to reduce blood pressure in the <a href="/wiki/Portal_vein" title="Portal vein" class="mw-redirect">portal vein</a>. Some patients may require <a href="/wiki/Dialysis" title="Dialysis">hemodialysis</a> to support kidney function, or a newer technique called <a href="/wiki/Liver_dialysis" title="Liver dialysis">liver dialysis</a> which uses a dialysis circuit with <a href="/wiki/Albumin" title="Albumin">albumin</a>-bound membranes to bind and remove toxins normally cleared by the liver, providing a means of <a href="/wiki/Artificial_extracorporeal_liver_support" title="Artificial extracorporeal liver support">extracorporeal liver support</a> until transplantation can be performed.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Classification"><span class="tocnumber">1</span> <span class="toctext">Classification</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Type_1_hepatorenal_syndrome"><span class="tocnumber">1.1</span> <span class="toctext">Type 1 hepatorenal syndrome</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Type_2_hepatorenal_syndrome"><span class="tocnumber">1.2</span> <span class="toctext">Type 2 hepatorenal syndrome</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><a href="#Signs_and_symptoms"><span class="tocnumber">2</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Causes"><span class="tocnumber">3</span> <span class="toctext">Causes</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#Diagnosis"><span class="tocnumber">4</span> <span class="toctext">Diagnosis</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Pathophysiology"><span class="tocnumber">5</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Prevention"><span class="tocnumber">6</span> <span class="toctext">Prevention</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#Treatment"><span class="tocnumber">7</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-10"><a href="#Transplantation"><span class="tocnumber">7.1</span> <span class="toctext">Transplantation</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Medical_therapy"><span class="tocnumber">7.2</span> <span class="toctext">Medical therapy</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Procedural_treatments"><span class="tocnumber">7.3</span> <span class="toctext">Procedural treatments</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-13"><a href="#Epidemiology"><span class="tocnumber">8</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#History"><span class="tocnumber">9</span> <span class="toctext">History</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#References"><span class="tocnumber">10</span> <span class="toctext">References</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=1" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Ascites_ultrasound_2.JPG" class="image"><img alt="Ultrasound showing ascites as a dark area in the abdomen" src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Ascites_ultrasound_2.JPG/220px-Ascites_ultrasound_2.JPG" width="220" height="169" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Ascites_ultrasound_2.JPG/330px-Ascites_ultrasound_2.JPG 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f8/Ascites_ultrasound_2.JPG/440px-Ascites_ultrasound_2.JPG 2x" data-file-width="629" data-file-height="484" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Ascites_ultrasound_2.JPG" class="internal" title="Enlarge"></a></div>
The development of <a href="/wiki/Ascites" title="Ascites">ascites</a> (as shown on this abdominal <a href="/wiki/Ultrasound" title="Ultrasound">ultrasound</a>) in <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhotics</a> that is refractory to the use of <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> medications is associated with type 2 HRS.</div>
</div>
</div>
<p>Hepatorenal syndrome is a particular and common type of <a href="/wiki/Renal_failure" title="Renal failure">kidney failure</a> that affects individuals with liver <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a> or, less commonly, with <a href="/wiki/Fulminant_liver_failure" title="Fulminant liver failure" class="mw-redirect">fulminant liver failure</a>.<sup id="cite_ref-Ng_1-0" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup> The syndrome involves constriction of the blood vessels of the <a href="/wiki/Kidney" title="Kidney">kidneys</a> and dilation of blood vessels in the splanchnic circulation, which supplies the intestines.<sup id="cite_ref-Ginesreview_2-0" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup> The classification of hepatorenal syndrome identifies two categories of <a href="/wiki/Kidney_failure" title="Kidney failure" class="mw-redirect">kidney failure</a>, termed <i>type 1</i> and <i>type 2</i> HRS, which both occur in individuals with either <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a> or <a href="/wiki/Fulminant_liver_failure" title="Fulminant liver failure" class="mw-redirect">fulminant liver failure</a>. In both categories, the deterioration in kidney function is quantified either by an elevation in <a href="/wiki/Creatinine" title="Creatinine">creatinine</a> level in the blood, or by <a href="/wiki/Creatinine_clearance" title="Creatinine clearance" class="mw-redirect">decreased clearance of creatinine in the urine</a>.<sup id="cite_ref-IAC_3-0" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Type_1_hepatorenal_syndrome">Type 1 hepatorenal syndrome</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=2" title="Edit section: Type 1 hepatorenal syndrome">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Type 1 HRS is characterized by rapidly progressive kidney failure, with a doubling of serum <a href="/wiki/Creatinine" title="Creatinine">creatinine</a> to a level greater than 221 <a href="/wiki/Micromole" title="Micromole" class="mw-redirect">μmol</a>/L (2.5 <a href="/wiki/Milligram" title="Milligram" class="mw-redirect">mg</a>/<a href="/wiki/Decilitre" title="Decilitre" class="mw-redirect">dL</a>) or a halving of the <a href="/wiki/Creatinine_clearance" title="Creatinine clearance" class="mw-redirect">creatinine clearance</a> to less than 20&#160;mL/min over a period of less than two weeks. The prognosis of individuals with type 1 HRS is particularly grim, with a <a href="/wiki/Mortality_rate" title="Mortality rate">mortality rate</a> exceeding 50% after one month.<sup id="cite_ref-Arroyo1_4-0" class="reference"><a href="#cite_note-Arroyo1-4"><span>[</span>4<span>]</span></a></sup> Patients with type 1 HRS are usually ill, may have <a href="/wiki/Hypotension" title="Hypotension">low blood pressure</a>, and may require therapy with drugs to improve the strength of heart muscle contraction (<a href="/wiki/Inotrope" title="Inotrope">inotropes</a>) or other drugs to maintain blood pressure (<a href="/wiki/Vasopressor" title="Vasopressor" class="mw-redirect">vasopressors</a>).<sup id="cite_ref-emed_5-0" class="reference"><a href="#cite_note-emed-5"><span>[</span>5<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Type_2_hepatorenal_syndrome">Type 2 hepatorenal syndrome</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=3" title="Edit section: Type 2 hepatorenal syndrome">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In contrast, type 2 HRS is slower in onset and progression. It is defined by an increase in serum <a href="/wiki/Creatinine" title="Creatinine">creatinine</a> level to &gt;133 μmol/L (1.5&#160;mg/dL) or a creatinine clearance of less than 40&#160;mL/min, and a urine sodium &lt; 10 μmol/L.<sup id="cite_ref-pmid3297907_6-0" class="reference"><a href="#cite_note-pmid3297907-6"><span>[</span>6<span>]</span></a></sup> It also carries a poor outlook, with a median survival of approximately six months unless the affected individual undergoes liver transplantation. Type 2 HRS is thought to be part of a spectrum of illness associated with <a href="/wiki/Portal_hypertension" title="Portal hypertension">increased pressures in the portal vein circulation</a>, which begins with the development of fluid in the abdomen (<a href="/wiki/Ascites" title="Ascites">ascites</a>). The spectrum continues with <i>diuretic-resistant ascites</i>, where the kidneys are unable to excrete sufficient sodium to clear the fluid even with the use of diuretic medications. Most individuals with type 2 HRS have diuretic-resistant ascites before they develop deterioration in kidney function.<sup id="cite_ref-Blendis_7-0" class="reference"><a href="#cite_note-Blendis-7"><span>[</span>7<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=4" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Both types of hepatorenal syndrome share three major components: altered liver function, abnormalities in circulation, and kidney failure. As these phenomena may not necessarily produce symptoms until late in their course, individuals with hepatorenal syndrome are typically diagnosed with the condition on the basis of altered laboratory tests. Most people who develop HRS have cirrhosis, and may have signs and symptoms of the same, which can include <a href="/wiki/Jaundice" title="Jaundice">jaundice</a>, <a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">altered mental status</a>, evidence of decreased nutrition, and the presence of <a href="/wiki/Ascites" title="Ascites">ascites</a>.<sup id="cite_ref-Ginesreview_2-1" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup> Specifically, the production of ascites that is resistant to the use of <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> medications is characteristic of type 2 HRS. <a href="/wiki/Oliguria" title="Oliguria">Oliguria</a>, which is a decrease in urine volume, may occur as a consequence of kidney failure; however, some individuals with HRS continue to produce a normal amount of urine.<sup id="cite_ref-IAC_3-1" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup> As these signs and symptoms may not necessarily occur in HRS, they are not included in the major and minor criteria for making a diagnosis of this condition; instead HRS is diagnosed in an individual at risk for the condition on the basis of the results of laboratory tests, and the exclusion of other causes.<sup id="cite_ref-IAC_3-2" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=5" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Hepatorenal syndrome usually affects individuals with <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a> and elevated pressures in the <a href="/wiki/Portal_vein" title="Portal vein" class="mw-redirect">portal vein</a> system (termed <a href="/wiki/Portal_hypertension" title="Portal hypertension">portal hypertension</a>). While HRS may develop in any type of <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a>, it is most common in individuals with <a href="/wiki/Cirrhosis" title="Cirrhosis">alcoholic cirrhosis</a>, particularly if there is concomitant <a href="/wiki/Alcoholic_hepatitis" title="Alcoholic hepatitis">alcoholic hepatitis</a> identifiable on liver biopsies.<sup id="cite_ref-GinesCohort_8-0" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup> HRS can also occur in individuals without cirrhosis, but with acute onset of liver failure, termed <a href="/wiki/Fulminant_liver_failure" title="Fulminant liver failure" class="mw-redirect">fulminant liver failure</a>.<sup id="cite_ref-IAC_3-3" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-GinesCohort_8-1" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup></p>
<p>Certain precipitants of HRS have been identified in vulnerable individuals with cirrhosis or fulminant liver failure. These include bacterial infection, acute <a href="/wiki/Alcoholic_hepatitis" title="Alcoholic hepatitis">alcoholic hepatitis</a>, or <a href="/wiki/Upper_gastrointestinal_hemorrhage" title="Upper gastrointestinal hemorrhage" class="mw-redirect">bleeding in the upper gastrointestinal tract</a>. <a href="/wiki/Spontaneous_bacterial_peritonitis" title="Spontaneous bacterial peritonitis">Spontaneous bacterial peritonitis</a>, which is the infection of <a href="/wiki/Ascites" title="Ascites">ascites</a> fluid, is the most common precipitant of HRS in cirrhotic individuals. HRS can sometimes be triggered by treatments for complications of liver disease: <a href="/wiki/Iatrogenic" title="Iatrogenic" class="mw-redirect">iatrogenic</a> precipitants of HRS include the aggressive use of <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> medications or the removal of large volumes of <a href="/wiki/Ascites" title="Ascites">ascitic fluid</a> by <a href="/wiki/Paracentesis" title="Paracentesis">paracentesis</a> from the abdominal cavity without compensating for fluid losses by intravenous replacement.<sup id="cite_ref-GinesCohort_8-2" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=6" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>There can be many causes of kidney failure in individuals with cirrhosis or fulminant liver failure. Consequently, it is a challenge to distinguish hepatorenal syndrome from other entities that cause kidney failure in the setting of advanced liver disease. As a result, additional major and minor criteria have been developed to assist in the <a href="/wiki/Diagnosis" title="Diagnosis">diagnosis</a> of hepatorenal syndrome.<sup id="cite_ref-IAC_3-4" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup></p>
<p>The <b>major</b> criteria include liver disease with <a href="/wiki/Portal_hypertension" title="Portal hypertension">portal hypertension</a>; <a href="/wiki/Kidney_failure" title="Kidney failure" class="mw-redirect">kidney failure</a>; the absence of <a href="/wiki/Shock_(circulatory)" title="Shock (circulatory)">shock</a>, <a href="/wiki/Infection" title="Infection">infection</a>, recent treatment with medications that affect the function of the kidney (<a href="/wiki/Nephrotoxin" title="Nephrotoxin" class="mw-redirect">nephrotoxins</a>), and fluid losses; the absence of sustained improvement in kidney function despite treatment with 1.5 litres of <a href="/wiki/Intravenous" title="Intravenous" class="mw-redirect">intravenous</a> <a href="/wiki/Normal_saline" title="Normal saline" class="mw-redirect">normal saline</a>; the absence of <a href="/wiki/Proteinuria" title="Proteinuria">proteinuria</a> (<a href="/wiki/Protein" title="Protein">protein</a> in the <a href="/wiki/Urine" title="Urine">urine</a>); and, the absence of kidney disease or obstruction of kidney outflow as seen on <a href="/wiki/Ultrasound" title="Ultrasound">ultrasound</a>.<sup id="cite_ref-IAC_3-5" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup></p>
<p>The <b>minor</b> criteria are the following: a <a href="/wiki/Oliguria" title="Oliguria">low urine volume</a> (less than 500&#160;mL (18&#160;imp&#160;fl&#160;oz; 17&#160;US&#160;fl&#160;oz) per day), low <a href="/wiki/Sodium" title="Sodium">sodium</a> concentration in the urine, a <a href="/wiki/Urine_osmolality" title="Urine osmolality">urine osmolality</a> that is greater than that in the <a href="/wiki/Blood" title="Blood">blood</a>, the absence of <a href="/wiki/Red_blood_cells" title="Red blood cells" class="mw-redirect">red blood cells</a> in the urine, and a serum sodium concentration of less than 130&#160;mmol/L.<sup id="cite_ref-IAC_3-6" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup></p>
<p>Many other diseases of the kidney are associated with liver disease and must be excluded before making a diagnosis of hepatorenal syndrome. Individuals with <a href="/wiki/Renal_failure" title="Renal failure">pre-renal kidney failure</a> do not have damage to the kidneys, but as in individuals with HRS, have kidney dysfunction due to decreased blood flow to the kidneys. Also, similarly to HRS, pre-renal kidney failure causes the formation of urine that has a very low sodium concentration. In contrast to HRS, however, pre-renal kidney failure usually responds to treatment with intravenous fluids, resulting in reduction in serum <a href="/wiki/Creatinine" title="Creatinine">creatinine</a> and increased excretion of sodium.<sup id="cite_ref-IAC_3-7" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup> <a href="/wiki/Acute_tubular_necrosis" title="Acute tubular necrosis">Acute tubular necrosis</a> (ATN) involves damage to the tubules of the kidney, and can be a complication in individuals with cirrhosis, because of exposure to toxic medications or the development of decreased blood pressure. Because of the damage to the tubules, ATN affected kidneys usually are unable to maximally resorb sodium from the urine. As a result, ATN can be distinguished from HRS on the basis of laboratory testing, as individuals with ATN will have urine sodium measurements that are much higher than in HRS; however, this may not always be the case in cirrhotics.<sup id="cite_ref-emed_5-1" class="reference"><a href="#cite_note-emed-5"><span>[</span>5<span>]</span></a></sup> Individuals with ATN also may have evidence of <a href="/wiki/Hyaline_cast" title="Hyaline cast" class="mw-redirect">hyaline casts</a> or <a href="/wiki/Muddy-brown_cast" title="Muddy-brown cast" class="mw-redirect">muddy-brown casts</a> in the urine on microscopy, whereas the urine of individuals with HRS is typically devoid of cellular material, as the kidneys have not been directly injured.<sup id="cite_ref-IAC_3-8" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup> Some viral infections of the liver, including <a href="/wiki/Hepatitis_B" title="Hepatitis B">hepatitis B</a> and <a href="/wiki/Hepatitis_C" title="Hepatitis C">hepatitis C</a> can also lead to inflammation of the <a href="/wiki/Glomerulonephritis" title="Glomerulonephritis">glomerulus</a> of the kidney.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9"><span>[</span>9<span>]</span></a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10"><span>[</span>10<span>]</span></a></sup> Other causes of kidney failure in individuals with liver disease include drug toxicity (notably the antibiotic <a href="/wiki/Gentamicin" title="Gentamicin">gentamicin</a>) or <a href="/wiki/Contrast_nephropathy" title="Contrast nephropathy" class="mw-redirect">contrast nephropathy</a>, caused by intravenous administration of <a href="/wiki/Contrast_medium" title="Contrast medium">contrast</a> agents used for medical imaging tests.<sup id="cite_ref-IAC_3-9" class="reference"><a href="#cite_note-IAC-3"><span>[</span>3<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=7" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:352px;"><a href="/wiki/File:HRS_and_ascites_pathophysiology.svg" class="image"><img alt="Diagram: portal hypertension leads to splanchnic vasoconstriction, which decreases effective cirulatory volume. This activates the renin–angiotensin–aldosterone system, which leads to ascites due to kidney sodium avidity and hepatorenal syndrome due to kidney vasoconstriction." src="//upload.wikimedia.org/wikipedia/commons/thumb/9/96/HRS_and_ascites_pathophysiology.svg/350px-HRS_and_ascites_pathophysiology.svg.png" width="350" height="228" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/96/HRS_and_ascites_pathophysiology.svg/525px-HRS_and_ascites_pathophysiology.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/96/HRS_and_ascites_pathophysiology.svg/700px-HRS_and_ascites_pathophysiology.svg.png 2x" data-file-width="946" data-file-height="617" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:HRS_and_ascites_pathophysiology.svg" class="internal" title="Enlarge"></a></div>
Schematic demonstrating the <i>underfill</i> theory to explain the pathophysiology of both <a href="/wiki/Ascites" title="Ascites">ascites</a> and hepatorenal syndrome.</div>
</div>
</div>
<div class="thumb tright">
<div class="thumbinner" style="width:402px;"><a href="/wiki/File:HRS_spectrum.svg" class="image"><img alt="Diagram: ascites, diuretic-resistant ascites and hepatorenal syndrome are a spectrum of clinical features. Portal hypertension is associated with all three. Splanchnic vasodilation is associated with all but ascites. Kidney vasoconstriction is associated only with HRS." src="//upload.wikimedia.org/wikipedia/commons/thumb/3/33/HRS_spectrum.svg/400px-HRS_spectrum.svg.png" width="400" height="171" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/33/HRS_spectrum.svg/600px-HRS_spectrum.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/33/HRS_spectrum.svg/800px-HRS_spectrum.svg.png 2x" data-file-width="1015" data-file-height="433" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:HRS_spectrum.svg" class="internal" title="Enlarge"></a></div>
Diagram showing hypothesized correlation between clinical features and pathophysiology of <a href="/wiki/Ascites" title="Ascites">ascites</a> and hepatorenal syndrome.</div>
</div>
</div>
<p>The <a href="/wiki/Kidney_failure" title="Kidney failure" class="mw-redirect">kidney failure</a> in hepatorenal syndrome is believed to arise from abnormalities in <a href="/wiki/Blood_vessel" title="Blood vessel">blood vessel</a> tone in the kidneys.<sup id="cite_ref-Ginesreview_2-2" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup> The predominant theory (termed the <i>underfill</i> theory) is that blood vessels in the kidney circulation are constricted because of the dilation of blood vessels in the <a href="/wiki/Splanchnic_circulation" title="Splanchnic circulation" class="mw-redirect">splanchnic circulation</a> (which supplies the <a href="/wiki/Intestines" title="Intestines" class="mw-redirect">intestines</a>), which is mediated by factors released by liver disease.<sup id="cite_ref-Arroyo1_4-1" class="reference"><a href="#cite_note-Arroyo1-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-Schrier_11-0" class="reference"><a href="#cite_note-Schrier-11"><span>[</span>11<span>]</span></a></sup> <a href="/wiki/Nitric_oxide" title="Nitric oxide">Nitric oxide</a>,<sup id="cite_ref-12" class="reference"><a href="#cite_note-12"><span>[</span>12<span>]</span></a></sup> <a href="/wiki/Prostaglandins" title="Prostaglandins" class="mw-redirect">prostaglandins</a>,<sup id="cite_ref-Ginesreview_2-3" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-13" class="reference"><a href="#cite_note-13"><span>[</span>13<span>]</span></a></sup> and other vasoactive substances<sup id="cite_ref-Ginesreview_2-4" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup> have been hypothesized as powerful mediators of splanchnic vasodilation in cirrhosis.<sup id="cite_ref-Ginesreview_2-5" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup> The consequence of this phenomenon is a decrease in the "effective" volume of blood sensed by the <a href="/wiki/Juxtaglomerular_apparatus" title="Juxtaglomerular apparatus">juxtaglomerular apparatus</a>, leading to the secretion of <a href="/wiki/Renin" title="Renin">renin</a> and the activation of the <a href="/wiki/Renin-angiotensin" title="Renin-angiotensin" class="mw-redirect">renin-angiotensin</a> system, which results in the vasoconstriction of vessels systemically and in the kidney specifically.<sup id="cite_ref-Ginesreview_2-6" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup> However, the effect of this is insufficient to counteract the mediators of vasodilation in the splanchnic circulation, leading to persistent "underfilling" of the kidney circulation and worsening kidney vasoconstriction, leading to kidney failure.<sup id="cite_ref-Schrier_11-1" class="reference"><a href="#cite_note-Schrier-11"><span>[</span>11<span>]</span></a></sup></p>
<p>Studies to quantify this theory have shown that there is an overall decreased <a href="/wiki/Systemic_vascular_resistance" title="Systemic vascular resistance" class="mw-redirect">systemic vascular resistance</a> in hepatorenal syndrome, but that the measured <a href="/wiki/Femoral_artery" title="Femoral artery">femoral</a> and kidney fractions of <a href="/wiki/Cardiac_output" title="Cardiac output">cardiac output</a> are respectively increased and reduced, suggesting that splanchnic <a href="/wiki/Vasodilation" title="Vasodilation">vasodilation</a> is implicated in the kidney failure.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup> Many vasoactive chemicals have been hypothesized as being involved in mediating the systemic hemodynamic changes, including <a href="/wiki/Atrial_natriuretic_factor" title="Atrial natriuretic factor" class="mw-redirect">atrial natriuretic factor</a>,<sup id="cite_ref-Lenz_15-0" class="reference"><a href="#cite_note-Lenz-15"><span>[</span>15<span>]</span></a></sup> <a href="/wiki/Prostacyclin" title="Prostacyclin">prostacyclin</a>, <a href="/wiki/Thromboxane" title="Thromboxane">thromboxane</a> A2,<sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> and <a href="/wiki/Endotoxin" title="Endotoxin" class="mw-redirect">endotoxin</a>.<sup id="cite_ref-Arroyo1_4-2" class="reference"><a href="#cite_note-Arroyo1-4"><span>[</span>4<span>]</span></a></sup> In addition to this, it has been observed that the administration of medications to counteract splanchnic vasodilation (such as <a href="/wiki/Ornipressin" title="Ornipressin">ornipressin</a>,<sup id="cite_ref-Lenz_15-1" class="reference"><a href="#cite_note-Lenz-15"><span>[</span>15<span>]</span></a></sup> <a href="/wiki/Terlipressin" title="Terlipressin">terlipressin</a>,<sup id="cite_ref-pmid11910344_17-0" class="reference"><a href="#cite_note-pmid11910344-17"><span>[</span>17<span>]</span></a></sup> and <a href="/wiki/Octreotide" title="Octreotide">octreotide</a>)<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> leads to improvement in <a href="/wiki/Glomerular_filtration_rate" title="Glomerular filtration rate" class="mw-redirect">glomerular filtration rate</a> (which is a quantitative measure of kidney function) in patients with hepatorenal syndrome, providing further evidence that splanchnic vasodilation is a key feature of its pathogenesis.</p>
<p>The underfill theory involves activation of the renin-angiotensin-aldosterone system, which leads to an increase in absorption of sodium from the kidney tubule (termed <i>renal sodium avidity</i>) mediated by <a href="/wiki/Aldosterone" title="Aldosterone">aldosterone</a>, which acts on <a href="/wiki/Mineralocorticoid_receptor" title="Mineralocorticoid receptor">mineralocorticoid receptors</a> in the <a href="/wiki/Distal_convoluted_tubule" title="Distal convoluted tubule">distal convoluted tubule</a>.<sup id="cite_ref-Blendis_7-1" class="reference"><a href="#cite_note-Blendis-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-Schrier_11-2" class="reference"><a href="#cite_note-Schrier-11"><span>[</span>11<span>]</span></a></sup> This is believed to be a key step in the pathogenesis of <a href="/wiki/Ascites" title="Ascites">ascites</a> in cirrhotics as well. It has been hypothesized that the progression from ascites to hepatorenal syndrome is a spectrum where splanchnic vasodilation defines both resistance to <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> medications in ascites (which is commonly seen in type 2 HRS) and the onset of kidney vasoconstriction (as described above) leading to hepatorenal syndrome.<sup id="cite_ref-Blendis_7-2" class="reference"><a href="#cite_note-Blendis-7"><span>[</span>7<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Prevention">Prevention</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=8" title="Edit section: Prevention">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Esophageal_varices_-_wale.jpg" class="image"><img alt="Purple longitudinal tubular structures with red spots in the esophagus at the time of endoscopy" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Esophageal_varices_-_wale.jpg/220px-Esophageal_varices_-_wale.jpg" width="220" height="204" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/b/b6/Esophageal_varices_-_wale.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/b/b6/Esophageal_varices_-_wale.jpg 2x" data-file-width="316" data-file-height="293" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Esophageal_varices_-_wale.jpg" class="internal" title="Enlarge"></a></div>
Picture of the <a href="/wiki/Esophagus" title="Esophagus">esophagus</a> at the time of <a href="/wiki/Esophagogastroduodenoscopy" title="Esophagogastroduodenoscopy">endoscopy</a> showing prominent <a href="/wiki/Esophageal_varices" title="Esophageal varices">esophageal varices</a>. Bleeding from esophageal varices can be a precipitant for hepatorenal syndrome in individuals with <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a>, and can be prevented by early diagnosis and treatment.</div>
</div>
</div>
<p>The risk of death in hepatorenal syndrome is very high; consequently, there is a significant emphasis on the identification of patients who are at risk for HRS, and prevention of triggers for onset of HRS. As <a href="/wiki/Infection" title="Infection">infection</a> (specifically <a href="/wiki/Spontaneous_bacterial_peritonitis" title="Spontaneous bacterial peritonitis">spontaneous bacterial peritonitis</a>) and <a href="/wiki/Upper_gastrointestinal_bleeding" title="Upper gastrointestinal bleeding">gastrointestinal hemorrhage</a> are both complications in individuals with cirrhosis, and are common triggers for HRS, specific care is made in early identification and treatment of cirrhotics with these complications to prevent HRS.<sup id="cite_ref-emed_5-2" class="reference"><a href="#cite_note-emed-5"><span>[</span>5<span>]</span></a></sup> Some of the triggers for HRS are induced by treatment of <a href="/wiki/Ascites" title="Ascites">ascites</a> and can be preventable. The aggressive use of <a href="/wiki/Diuretic" title="Diuretic">diuretic</a> medications should be avoided. In addition, many medications that are either used to treat cirrhotic complications (such as some antibiotics) or other conditions may cause sufficient impairment in kidney function in the cirrhotic to lead to HRS.<sup id="cite_ref-Arroyo1_4-3" class="reference"><a href="#cite_note-Arroyo1-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-emed_5-3" class="reference"><a href="#cite_note-emed-5"><span>[</span>5<span>]</span></a></sup> Also, large volume <a href="/wiki/Paracentesis" title="Paracentesis">paracentesis</a>—which is the removal of <a href="/wiki/Ascites" title="Ascites">ascites</a> fluid from the abdomen using a needle or <a href="/wiki/Angiocath" title="Angiocath" class="mw-redirect">catheter</a> in order to relieve discomfort—may cause enough alteration in hemodynamics to precipitate HRS, and should be avoided in individuals at risk. The concomitant infusion of <a href="/wiki/Albumin" title="Albumin">albumin</a> can avert the circulatory dysfunction that occurs after large volume paracentesis, and may prevent HRS.<sup id="cite_ref-19" class="reference"><a href="#cite_note-19"><span>[</span>19<span>]</span></a></sup> Conversely, in individuals with very tense ascites, it has been hypothesized that removal of ascitic fluid may improve kidney function if it decreases the pressure on the <a href="/wiki/Renal_vein" title="Renal vein">renal veins</a>.<sup id="cite_ref-Sherlock_20-0" class="reference"><a href="#cite_note-Sherlock-20"><span>[</span>20<span>]</span></a></sup></p>
<p>Individuals with ascites that has become infected spontaneously (termed <a href="/wiki/Spontaneous_bacterial_peritonitis" title="Spontaneous bacterial peritonitis">spontaneous bacterial peritonitis</a> or SBP) are at an especially high risk for the development of HRS.<sup id="cite_ref-Ginesreview_2-7" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup> In individuals with SBP, one <a href="/wiki/Randomized_controlled_trial" title="Randomized controlled trial">randomized controlled trial</a> found that the administration of intravenous albumin on the day of admission and on the third day in hospital reduced both the rate of kidney insufficiency and the mortality rate.<sup id="cite_ref-pmid10432325_21-0" class="reference"><a href="#cite_note-pmid10432325-21"><span>[</span>21<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=9" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Transplantation">Transplantation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=10" title="Edit section: Transplantation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>The definitive treatment for hepatorenal syndrome is <a href="/wiki/Liver_transplantation" title="Liver transplantation">liver transplantation</a>, and all other therapies can best be described as bridges to transplantation.<sup id="cite_ref-Ng_1-1" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-FloWo_22-0" class="reference"><a href="#cite_note-FloWo-22"><span>[</span>22<span>]</span></a></sup> While liver transplantation is by far the best available management option for HRS, the mortality of individuals with HRS has been shown to be as high as 25% within the first month after transplantation.<sup id="cite_ref-Xu_23-0" class="reference"><a href="#cite_note-Xu-23"><span>[</span>23<span>]</span></a></sup> Individuals with HRS and evidence of greater hepatic dysfunction (quantified as <a href="/wiki/Model_for_end-stage_liver_disease" title="Model for end-stage liver disease" class="mw-redirect">MELD</a> scores above 36) have been found to be at greatest risk of early mortality after liver transplantation.<sup id="cite_ref-Xu_23-1" class="reference"><a href="#cite_note-Xu-23"><span>[</span>23<span>]</span></a></sup> A further deterioration of kidney function even after liver transplantation in individuals with HRS has been demonstrated in several studies; however, this is transient and thought to be due to the use of <a href="/wiki/Nephrotoxin" title="Nephrotoxin" class="mw-redirect">medications with toxicity to the kidneys</a>, and specifically the introduction of <a href="/wiki/Immunosuppressant" title="Immunosuppressant" class="mw-redirect">immunosuppressants</a> such as <a href="/wiki/Tacrolimus" title="Tacrolimus">tacrolimus</a> and <a href="/wiki/Cyclosporine" title="Cyclosporine" class="mw-redirect">cyclosporine</a> that are known to worsen kidney function.<sup id="cite_ref-Ginesreview_2-8" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup> Over the long-term, however, individuals with HRS who are the recipients of liver transplants almost universally recover kidney function, and studies show that their survival rates at three years are similar to those who have received liver transplants for reasons other than HRS.<sup id="cite_ref-Ng_1-2" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Ginesreview_2-9" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup></p>
<p>In anticipation of liver transplantation (which may be associated with considerable in-hospital delay), several other strategies have been found to be beneficial in preserving kidney function. These include the use of intravenous <a href="/wiki/Albumin" title="Albumin">albumin</a> infusion, medications (for which the best evidence is for analogues of <a href="/wiki/Vasopressin" title="Vasopressin">vasopressin</a>, which causes splanchnic vasoconstriction), radiological shunts to decrease <a href="/wiki/Portal_hypertension" title="Portal hypertension">pressure in the portal vein</a>, <a href="/wiki/Dialysis" title="Dialysis">dialysis</a>, and a specialized albumin-bound membrane dialysis system termed <a href="/wiki/Molecular_adsorbents_recirculation_system" title="Molecular adsorbents recirculation system" class="mw-redirect">molecular adsorbents recirculation system</a> (MARS) or <a href="/wiki/Liver_dialysis" title="Liver dialysis">liver dialysis</a>.<sup id="cite_ref-Ginesreview_2-10" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Medical_therapy">Medical therapy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=11" title="Edit section: Medical therapy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Many major studies showing improvement in kidney function in patients with hepatorenal syndrome have involved expansion of the volume of the <a href="/wiki/Blood_plasma" title="Blood plasma">plasma</a> with <a href="/wiki/Human_serum_albumin" title="Human serum albumin">albumin</a> given intravenously.<sup id="cite_ref-Ginesreview_2-11" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-Guevara_24-0" class="reference"><a href="#cite_note-Guevara-24"><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-Terli_25-0" class="reference"><a href="#cite_note-Terli-25"><span>[</span>25<span>]</span></a></sup> The quantity of albumin administered intravenously varies: one cited regimen is 1 gram of albumin per kilogram of body weight intravenously on the first day, followed by 20 to 40 grams daily.<sup id="cite_ref-pmid15084697_26-0" class="reference"><a href="#cite_note-pmid15084697-26"><span>[</span>26<span>]</span></a></sup> Notably, studies have shown that treatment with albumin alone is inferior to treatment with other medications in conjunction with albumin; most studies evaluating pre-transplant therapies for HRS involve the use of albumin in conjunction with other medical or procedural treatment.<sup id="cite_ref-Ginesreview_2-12" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-27" class="reference"><a href="#cite_note-27"><span>[</span>27<span>]</span></a></sup></p>
<p><a href="/wiki/Midodrine" title="Midodrine">Midodrine</a> is an <a href="/wiki/Adrenergic_agonist" title="Adrenergic agonist">alpha-agonist</a> and <a href="/wiki/Octreotide" title="Octreotide">octreotide</a> is an analogue of <a href="/wiki/Somatostatin" title="Somatostatin">somatostatin</a>, a hormone involved in regulation of <a href="/wiki/Splanchnic_circulation" title="Splanchnic circulation" class="mw-redirect">blood vessel tone in the gastrointestinal tract</a>. The medications are respectively systemic vasoconstrictors and inhibitors of splanchnic vasodilation, and were not found to be useful when used individually in treatment of hepatorenal syndrome.<sup id="cite_ref-Ng_1-3" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Ginesreview_2-13" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup><sup id="cite_ref-28" class="reference"><a href="#cite_note-28"><span>[</span>28<span>]</span></a></sup> However, one study of 13 patients with hepatorenal syndrome showed significant improvement in kidney function when the two were used together (with midodrine given orally, octreotide given <a href="/wiki/Subcutaneous_injection" title="Subcutaneous injection">subcutaneously</a> and both dosed according to blood pressure), with three patients surviving to discharge.<sup id="cite_ref-Angeli_29-0" class="reference"><a href="#cite_note-Angeli-29"><span>[</span>29<span>]</span></a></sup> Another nonrandomized, observational study of individuals with HRS treated with subcutaneous octreotide and oral midodrine showed that there was increased survival at 30 days.<sup id="cite_ref-Ng_1-4" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-pmid17235705_30-0" class="reference"><a href="#cite_note-pmid17235705-30"><span>[</span>30<span>]</span></a></sup></p>
<p>The <a href="/wiki/Vasopressin#Pharmacology" title="Vasopressin">vasopressin analogue</a> <a href="/wiki/Ornipressin" title="Ornipressin">ornipressin</a> was found in a number of studies to be useful in improvement of kidney function in patients with hepatorenal syndrome,<sup id="cite_ref-Ng_1-5" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Guevara_24-1" class="reference"><a href="#cite_note-Guevara-24"><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup> but has been limited in its use, as it can cause severe <a href="/wiki/Ischemia" title="Ischemia">ischemia</a> to major organs.<sup id="cite_ref-Ng_1-6" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Guevara_24-2" class="reference"><a href="#cite_note-Guevara-24"><span>[</span>24<span>]</span></a></sup> <a href="/wiki/Terlipressin" title="Terlipressin">Terlipressin</a> is a vasopressin analogue that has been found in one large study to be useful for improving kidney function in patients with hepatorenal syndrome with a lesser incidence of ischemia but is not available in the United States.<sup id="cite_ref-Ng_1-7" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Terli_25-1" class="reference"><a href="#cite_note-Terli-25"><span>[</span>25<span>]</span></a></sup> A key criticism of all of these medical therapies has been heterogeneity in the populations investigated and the use of kidney function, instead of mortality, as an outcome measure.<sup id="cite_ref-32" class="reference"><a href="#cite_note-32"><span>[</span>32<span>]</span></a></sup></p>
<p>Other agents that have been investigated for use in treatment of HRS include <a href="/wiki/Pentoxifylline" title="Pentoxifylline">pentoxifylline</a>,<sup id="cite_ref-PTX_33-0" class="reference"><a href="#cite_note-PTX-33"><span>[</span>33<span>]</span></a></sup> <a href="/wiki/Acetylcysteine" title="Acetylcysteine">acetylcysteine</a>,<sup id="cite_ref-34" class="reference"><a href="#cite_note-34"><span>[</span>34<span>]</span></a></sup> and <a href="/wiki/Misoprostol" title="Misoprostol">misoprostol</a>.<sup id="cite_ref-Ng_1-8" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-35" class="reference"><a href="#cite_note-35"><span>[</span>35<span>]</span></a></sup> The evidence for all of these therapies is based on either <a href="/wiki/Case_series" title="Case series">case series</a>, or in the case of pentoxifylline, extrapolated from a subset of patients treated for <a href="/wiki/Alcoholic_hepatitis" title="Alcoholic hepatitis">alcoholic hepatitis</a>.<sup id="cite_ref-Ng_1-9" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Procedural_treatments">Procedural treatments</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=12" title="Edit section: Procedural treatments">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Fluoroscopic_image_of_transjugular_intrahepatic_portosystemic_shunt_(TIPS)_in_progress.jpg" class="image"><img alt="X-ray of a tube being inserted between two black contrast-filled veins" src="//upload.wikimedia.org/wikipedia/commons/thumb/8/87/Fluoroscopic_image_of_transjugular_intrahepatic_portosystemic_shunt_%28TIPS%29_in_progress.jpg/220px-Fluoroscopic_image_of_transjugular_intrahepatic_portosystemic_shunt_%28TIPS%29_in_progress.jpg" width="220" height="258" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/87/Fluoroscopic_image_of_transjugular_intrahepatic_portosystemic_shunt_%28TIPS%29_in_progress.jpg/330px-Fluoroscopic_image_of_transjugular_intrahepatic_portosystemic_shunt_%28TIPS%29_in_progress.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/87/Fluoroscopic_image_of_transjugular_intrahepatic_portosystemic_shunt_%28TIPS%29_in_progress.jpg/440px-Fluoroscopic_image_of_transjugular_intrahepatic_portosystemic_shunt_%28TIPS%29_in_progress.jpg 2x" data-file-width="469" data-file-height="549" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Fluoroscopic_image_of_transjugular_intrahepatic_portosystemic_shunt_(TIPS)_in_progress.jpg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Transjugular_intrahepatic_portosystemic_shunt" title="Transjugular intrahepatic portosystemic shunt">TIPS</a>, shown in progress here, has been shown to improve kidney function in individuals with HRS if portal pressures decrease after the procedure.</div>
</div>
</div>
<p>A <a href="/wiki/Transjugular_intrahepatic_portosystemic_shunt" title="Transjugular intrahepatic portosystemic shunt">transjugular intrahepatic portosystemic shunt</a> (TIPS) involves the decompression of the high pressures in the <a href="/wiki/Portal_hypertension" title="Portal hypertension">portal</a> circulation by placing a small stent between a <a href="/wiki/Hepatic_portal_vein" title="Hepatic portal vein">portal</a> and <a href="/wiki/Hepatic_vein" title="Hepatic vein">hepatic vein</a>. This is done through radiologically guided catheters which are passed into the hepatic vein either through the <a href="/wiki/Internal_jugular_vein" title="Internal jugular vein">internal jugular vein</a> or the <a href="/wiki/Femoral_vein" title="Femoral vein">femoral vein</a>. Theoretically, a decrease in portal pressures is thought to reverse the hemodynamic phenomena that ultimately lead to the development of hepatorenal syndrome. TIPS has been shown to improve kidney function in patients with hepatorenal syndrome.<sup id="cite_ref-Blendis_7-3" class="reference"><a href="#cite_note-Blendis-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-TIPS_36-0" class="reference"><a href="#cite_note-TIPS-36"><span>[</span>36<span>]</span></a></sup><sup id="cite_ref-37" class="reference"><a href="#cite_note-37"><span>[</span>37<span>]</span></a></sup> Complications of TIPS for treatment of HRS include the worsening of <a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">hepatic encephalopathy</a> (as the procedure involves the forced creation of a porto-systemic shunt, effectively bypassing the ability of the liver to clear toxins), inability to achieve adequate reduction in portal pressure, and bleeding.<sup id="cite_ref-Blendis_7-4" class="reference"><a href="#cite_note-Blendis-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-TIPS_36-1" class="reference"><a href="#cite_note-TIPS-36"><span>[</span>36<span>]</span></a></sup></p>
<p><a href="/wiki/Liver_dialysis" title="Liver dialysis">Liver dialysis</a> involves extracorporeal dialysis to remove toxins from the circulation, usually through the addition of a second dialysis circuit that contains an albumin-bound membrane. The <a href="/wiki/Liver_dialysis#Liver_dialysis_devices" title="Liver dialysis">molecular adsorbents recirculation system</a> (MARS) has shown some utility as a bridge to transplantation in patients with hepatorenal syndrome, yet the technique is still nascent.<sup id="cite_ref-Blendis_7-5" class="reference"><a href="#cite_note-Blendis-7"><span>[</span>7<span>]</span></a></sup><sup id="cite_ref-38" class="reference"><a href="#cite_note-38"><span>[</span>38<span>]</span></a></sup></p>
<p><a href="/wiki/Renal_replacement_therapy" title="Renal replacement therapy">Renal replacement therapy</a> may be required to bridge individuals with hepatorenal syndrome to liver transplantation, although the condition of the patient may dictate the modality used.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup> The use of <a href="/wiki/Dialysis" title="Dialysis">dialysis</a>, however, does not lead to recuperation or preservation of kidney function in patients with HRS, and is essentially only used to avoid complications of kidney failure until transplantation can take place. In patients who undergo <a href="/wiki/Hemodialysis" title="Hemodialysis">hemodialysis</a>, there may even be an increased risk of mortality due to <a href="/wiki/Hypotension" title="Hypotension">low blood pressure</a> in patients with HRS, although appropriate studies have yet to be performed. As a result, the role of renal replacement therapy in patients with HRS remains unclear.<sup id="cite_ref-Ginesreview_2-14" class="reference"><a href="#cite_note-Ginesreview-2"><span>[</span>2<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=13" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>As the majority of individuals with hepatorenal syndrome have <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a>, much of the epidemiological data on HRS comes from the cirrhotic population. The condition is quite common: approximately 10% of individuals admitted to hospital with <a href="/wiki/Ascites" title="Ascites">ascites</a> have HRS.<sup id="cite_ref-GinesCohort_8-3" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup> A retrospective case series of cirrhotic patients treated with terlipressin suggested that 20.0% of acute kidney failure in cirrhotics was due to type 1 HRS, and 6.6% was due to type 2 HRS.<sup id="cite_ref-pmid11910344_17-1" class="reference"><a href="#cite_note-pmid11910344-17"><span>[</span>17<span>]</span></a></sup> It is estimated that 18% of individuals with <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a> and <a href="/wiki/Ascites" title="Ascites">ascites</a> will develop HRS within one year of their diagnosis with cirrhosis, and 39% of these individuals will develop HRS within five years of diagnosis.<sup id="cite_ref-GinesCohort_8-4" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup> Three independent risk factors for the development of HRS in cirrhotics have been identified: liver size, plasma renin activity, and serum sodium concentration.<sup id="cite_ref-GinesCohort_8-5" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup></p>
<p>The prognosis of these patients is grim with untreated patients having an extremely short survival.<sup id="cite_ref-Arroyo1_4-4" class="reference"><a href="#cite_note-Arroyo1-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-GinesCohort_8-6" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-FloWo_22-1" class="reference"><a href="#cite_note-FloWo-22"><span>[</span>22<span>]</span></a></sup> The severity of liver disease (as evidenced by the <a href="/wiki/Model_for_End-Stage_Liver_Disease" title="Model for End-Stage Liver Disease">MELD</a> score) has been shown to be a determinant of outcome.<sup id="cite_ref-Xu_23-2" class="reference"><a href="#cite_note-Xu-23"><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span>[</span>40<span>]</span></a></sup> Some patients without cirrhosis develop HRS, with an incidence of about 20% seen in one study of ill patients with <a href="/wiki/Alcoholic_hepatitis" title="Alcoholic hepatitis">alcoholic hepatitis</a>.<sup id="cite_ref-PTX_33-1" class="reference"><a href="#cite_note-PTX-33"><span>[</span>33<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=14" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The first reports of kidney failure occurring in individuals with chronic liver diseases were from the late 19th century by Frerichs and Flint.<sup id="cite_ref-GinesCohort_8-7" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup> However, the hepatorenal syndrome was first defined as acute kidney failure that occurred in the setting of <a href="/wiki/Biliary_system" title="Biliary system" class="mw-redirect">biliary surgery</a>.<sup id="cite_ref-Ng_1-10" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-41" class="reference"><a href="#cite_note-41"><span>[</span>41<span>]</span></a></sup> The syndrome was soon re-associated with advanced liver disease,<sup id="cite_ref-FloWo_22-2" class="reference"><a href="#cite_note-FloWo-22"><span>[</span>22<span>]</span></a></sup> and, in the 1950s, was clinically defined by <a href="/wiki/Sheila_Sherlock" title="Sheila Sherlock">Sherlock</a>, Hecker, Papper and Vessin as being associated with systemic hemodynamic abnormalities and high mortality.<sup id="cite_ref-GinesCohort_8-8" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup><sup id="cite_ref-pmid13377688_42-0" class="reference"><a href="#cite_note-pmid13377688-42"><span>[</span>42<span>]</span></a></sup> Hecker and Sherlock specifically identified that individuals with HRS had low urinary output, very low <a href="/wiki/Sodium" title="Sodium">sodium</a> in the urine, and no protein in the urine.<sup id="cite_ref-Ng_1-11" class="reference"><a href="#cite_note-Ng-1"><span>[</span>1<span>]</span></a></sup> Murray Epstein was the first to characterize splanchnic vasodilation and kidney vasoconstriction as the key alterations in hemodynamics in patients with the syndrome.<sup id="cite_ref-pmid17699328_43-0" class="reference"><a href="#cite_note-pmid17699328-43"><span>[</span>43<span>]</span></a></sup> The functional nature of the kidney impairment in HRS was crystallized by studies demonstrating that kidneys transplanted from patients with hepatorenal syndrome returned to function in the new host,<sup id="cite_ref-44" class="reference"><a href="#cite_note-44"><span>[</span>44<span>]</span></a></sup> leading to the hypothesis that hepatorenal syndrome was a systemic condition and not a kidney disease. The first systematic attempt to define hepatorenal syndrome was made in 1994 by the International Ascites Club, a group of <a href="/wiki/Hepatologist" title="Hepatologist" class="mw-redirect">liver specialists</a>. The more recent history of HRS has involved elucidation of the various vasoactive mediators that cause the splanchnic and kidney blood flow abnormalities of the condition.<sup id="cite_ref-GinesCohort_8-9" class="reference"><a href="#cite_note-GinesCohort-8"><span>[</span>8<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit&amp;section=15" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Ng-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ng_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ng_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ng_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Ng_1-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Ng_1-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Ng_1-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Ng_1-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Ng_1-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Ng_1-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Ng_1-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Ng_1-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Ng_1-11"><sup><i><b>l</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ng CK, Chan MH, Tai MH, Lam CW (February 2007). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1904420">"Hepatorenal syndrome"</a>. <i>Clin Biochem Rev</i> <b>28</b> (1): 11–7. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC1904420">1904420</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17603637">17603637</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Hepatorenal+syndrome&amp;rft.aulast=Ng+CK%2C+Chan+MH%2C+Tai+MH%2C+Lam+CW&amp;rft.au=Ng+CK%2C+Chan+MH%2C+Tai+MH%2C+Lam+CW&amp;rft.date=February+2007&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1904420&amp;rft_id=info%3Apmc%2F1904420&amp;rft_id=info%3Apmid%2F17603637&amp;rft.issue=1&amp;rft.jtitle=Clin+Biochem+Rev&amp;rft.pages=11-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Ginesreview-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ginesreview_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Ginesreview_2-14"><sup><i><b>o</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ginès P, Arroyo V (1999). <a rel="nofollow" class="external text" href="http://jasn.asnjournals.org/cgi/content/full/10/8/1833">"Hepatorenal syndrome"</a>. <i>J. Am. Soc. Nephrol.</i> <b>10</b> (8): 1833–9. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10446954">10446954</a><span class="reference-accessdate">. Retrieved <span class="nowrap">17 July</span> 2009</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Hepatorenal+syndrome&amp;rft.au=Gin%C3%A8s+P%2C+Arroyo+V&amp;rft.aulast=Gin%C3%A8s+P%2C+Arroyo+V&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fjasn.asnjournals.org%2Fcgi%2Fcontent%2Ffull%2F10%2F8%2F1833&amp;rft_id=info%3Apmid%2F10446954&amp;rft.issue=8&amp;rft.jtitle=J.+Am.+Soc.+Nephrol.&amp;rft.pages=1833-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=10" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-IAC-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-IAC_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IAC_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IAC_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-IAC_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-IAC_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-IAC_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-IAC_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-IAC_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-IAC_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-IAC_3-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Arroyo V, Ginès P, Gerbes AL et al. (1996). "Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club". <i>Hepatology</i> <b>23</b> (1): 164–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fhep.510230122">10.1002/hep.510230122</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8550036">8550036</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Definition+and+diagnostic+criteria+of+refractory+ascites+and+hepatorenal+syndrome+in+cirrhosis.+International+Ascites+Club&amp;rft.au=Arroyo+V%2C+Gin%C3%A8s+P%2C+Gerbes+AL&amp;rft.aulast=Arroyo+V%2C+Gin%C3%A8s+P%2C+Gerbes+AL&amp;rft.date=1996&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.510230122&amp;rft_id=info%3Apmid%2F8550036&amp;rft.issue=1&amp;rft.jtitle=Hepatology&amp;rft.pages=164-76&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=23" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Arroyo1-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Arroyo1_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Arroyo1_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Arroyo1_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Arroyo1_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Arroyo1_4-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Arroyo V, Guevara M, Ginès P (2002). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0016508502090066">"Hepatorenal syndrome in cirrhosis: pathogenesis and treatment"</a>. <i>Gastroenterology</i> <b>122</b> (6): 1658–76. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fgast.2002.33575">10.1053/gast.2002.33575</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12016430">12016430</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Hepatorenal+syndrome+in+cirrhosis%3A+pathogenesis+and+treatment&amp;rft.au=Arroyo+V%2C+Guevara+M%2C+Gin%C3%A8s+P&amp;rft.aulast=Arroyo+V%2C+Guevara+M%2C+Gin%C3%A8s+P&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0016508502090066&amp;rft_id=info%3Adoi%2F10.1053%2Fgast.2002.33575&amp;rft_id=info%3Apmid%2F12016430&amp;rft.issue=6&amp;rft.jtitle=Gastroenterology&amp;rft.pages=1658-76&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=122" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-emed-5"><span class="mw-cite-backlink">^ <a href="#cite_ref-emed_5-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-emed_5-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-emed_5-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-emed_5-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text">Mukherjee, S. <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/178208-overview">Hepatorenal syndrome.</a> emedicine.com. Retrieved on 2 August 2009</span></li>
<li id="cite_note-pmid3297907-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid3297907_6-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ginés P, Arroyo V, Quintero E et al. (1987). "Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study". <i>Gastroenterology</i> <b>93</b> (2): 234–41. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/3297907">3297907</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Comparison+of+paracentesis+and+diuretics+in+the+treatment+of+cirrhotics+with+tense+ascites.+Results+of+a+randomized+study&amp;rft.au=Gin%C3%A9s+P%2C+Arroyo+V%2C+Quintero+E&amp;rft.aulast=Gin%C3%A9s+P%2C+Arroyo+V%2C+Quintero+E&amp;rft.date=1987&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F3297907&amp;rft.issue=2&amp;rft.jtitle=Gastroenterology&amp;rft.pages=234-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=93" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Blendis-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-Blendis_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Blendis_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Blendis_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Blendis_7-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Blendis_7-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Blendis_7-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Blendis L, Wong F (2003). <a rel="nofollow" class="external text" href="http://openurl.ingenta.com/content/nlm?genre=article&amp;issn=1470-2118&amp;volume=3&amp;issue=2&amp;spage=154&amp;aulast=Blendis">"The natural history and management of hepatorenal disorders: from pre-ascites to hepatorenal syndrome"</a>. <i>Clin Med</i> <b>3</b> (2): 154–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7861%2Fclinmedicine.3-2-154">10.7861/clinmedicine.3-2-154</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12737373">12737373</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=The+natural+history+and+management+of+hepatorenal+disorders%3A+from+pre-ascites+to+hepatorenal+syndrome&amp;rft.au=Blendis+L%2C+Wong+F&amp;rft.aulast=Blendis+L%2C+Wong+F&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fopenurl.ingenta.com%2Fcontent%2Fnlm%3Fgenre%3Darticle%26issn%3D1470-2118%26volume%3D3%26issue%3D2%26spage%3D154%26aulast%3DBlendis&amp;rft_id=info%3Adoi%2F10.7861%2Fclinmedicine.3-2-154&amp;rft_id=info%3Apmid%2F12737373&amp;rft.issue=2&amp;rft.jtitle=Clin+Med&amp;rft.pages=154-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-GinesCohort-8"><span class="mw-cite-backlink">^ <a href="#cite_ref-GinesCohort_8-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-GinesCohort_8-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-GinesCohort_8-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-GinesCohort_8-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-GinesCohort_8-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-GinesCohort_8-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-GinesCohort_8-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-GinesCohort_8-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-GinesCohort_8-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-GinesCohort_8-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ginès A, Escorsell A, Ginès P et al. (1993). "Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites". <i>Gastroenterology</i> <b>105</b> (1): 229–36. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8514039">8514039</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Incidence%2C+predictive+factors%2C+and+prognosis+of+the+hepatorenal+syndrome+in+cirrhosis+with+ascites&amp;rft.au=Gin%C3%A8s+A%2C+Escorsell+A%2C+Gin%C3%A8s+P&amp;rft.aulast=Gin%C3%A8s+A%2C+Escorsell+A%2C+Gin%C3%A8s+P&amp;rft.date=1993&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8514039&amp;rft.issue=1&amp;rft.jtitle=Gastroenterology&amp;rft.pages=229-36&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=105" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><span class="citation journal">Han SH (2004). "Extrahepatic manifestations of chronic hepatitis B". <i>Clin Liver Dis</i> <b>8</b> (2): 403–18. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.cld.2004.02.003">10.1016/j.cld.2004.02.003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15481347">15481347</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Extrahepatic+manifestations+of+chronic+hepatitis+B&amp;rft.au=Han+SH&amp;rft.aulast=Han+SH&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cld.2004.02.003&amp;rft_id=info%3Apmid%2F15481347&amp;rft.issue=2&amp;rft.jtitle=Clin+Liver+Dis&amp;rft.pages=403-18&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><span class="citation journal">Philipneri M, Bastani B (February 2001). "Kidney disease in patients with chronic hepatitis C". <i>Curr Gastroenterol Rep</i> <b>3</b> (1): 79–83. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs11894-001-0045-0">10.1007/s11894-001-0045-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11177699">11177699</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Kidney+disease+in+patients+with+chronic+hepatitis+C&amp;rft.aulast=Philipneri+M%2C+Bastani+B&amp;rft.au=Philipneri+M%2C+Bastani+B&amp;rft.date=February+2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs11894-001-0045-0&amp;rft_id=info%3Apmid%2F11177699&amp;rft.issue=1&amp;rft.jtitle=Curr+Gastroenterol+Rep&amp;rft.pages=79-83&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Schrier-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-Schrier_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Schrier_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Schrier_11-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J (1988). "Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis". <i>Hepatology</i> <b>8</b> (5): 1151–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fhep.1840080532">10.1002/hep.1840080532</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2971015">2971015</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Peripheral+arterial+vasodilation+hypothesis%3A+a+proposal+for+the+initiation+of+renal+sodium+and+water+retention+in+cirrhosis&amp;rft.aulast=Schrier+RW%2C+Arroyo+V%2C+Bernardi+M%2C+Epstein+M%2C+Henriksen+JH%2C+Rod%C3%A9s+J&amp;rft.au=Schrier+RW%2C+Arroyo+V%2C+Bernardi+M%2C+Epstein+M%2C+Henriksen+JH%2C+Rod%C3%A9s+J&amp;rft.date=1988&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.1840080532&amp;rft_id=info%3Apmid%2F2971015&amp;rft.issue=5&amp;rft.jtitle=Hepatology&amp;rft.pages=1151-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=8" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><span class="citation journal">Martin PY, Ginès P, Schrier RW (August 1998). "Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis". <i>N. Engl. J. Med.</i> <b>339</b> (8): 533–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199808203390807">10.1056/NEJM199808203390807</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9709047">9709047</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Nitric+oxide+as+a+mediator+of+hemodynamic+abnormalities+and+sodium+and+water+retention+in+cirrhosis&amp;rft.aulast=Martin+PY%2C+Gin%C3%A8s+P%2C+Schrier+RW&amp;rft.au=Martin+PY%2C+Gin%C3%A8s+P%2C+Schrier+RW&amp;rft.date=August+1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199808203390807&amp;rft_id=info%3Apmid%2F9709047&amp;rft.issue=8&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=533-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=339" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><span class="citation journal">Epstein M (April 1994). "Hepatorenal syndrome: emerging perspectives of pathophysiology and therapy". <i>J. Am. Soc. Nephrol.</i> <b>4</b> (10): 1735–53. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8068872">8068872</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Hepatorenal+syndrome%3A+emerging+perspectives+of+pathophysiology+and+therapy&amp;rft.au=Epstein+M&amp;rft.aulast=Epstein+M&amp;rft.date=April+1994&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8068872&amp;rft.issue=10&amp;rft.jtitle=J.+Am.+Soc.+Nephrol.&amp;rft.pages=1735-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">Fernandez-Seara J, Prieto J, Quiroga J et al. (1989). "Systemic and regional hemodynamics in patients with liver cirrhosis and ascites with and without functional renal failure". <i>Gastroenterology</i> <b>97</b> (5): 1304–12. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2676683">2676683</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Systemic+and+regional+hemodynamics+in+patients+with+liver+cirrhosis+and+ascites+with+and+without+functional+renal+failure&amp;rft.au=Fernandez-Seara+J%2C+Prieto+J%2C+Quiroga+J&amp;rft.aulast=Fernandez-Seara+J%2C+Prieto+J%2C+Quiroga+J&amp;rft.date=1989&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2676683&amp;rft.issue=5&amp;rft.jtitle=Gastroenterology&amp;rft.pages=1304-12&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=97" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Lenz-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lenz_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lenz_15-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Lenz K, Hörtnagl H, Druml W et al. (1991). "Ornipressin in the treatment of functional renal failure in decompensated liver cirrhosis. Effects on renal hemodynamics and atrial natriuretic factor". <i>Gastroenterology</i> <b>101</b> (4): 1060–7. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/1832407">1832407</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Ornipressin+in+the+treatment+of+functional+renal+failure+in+decompensated+liver+cirrhosis.+Effects+on+renal+hemodynamics+and+atrial+natriuretic+factor&amp;rft.aulast=Lenz+K%2C+H%C3%B6rtnagl+H%2C+Druml+W&amp;rft.au=Lenz+K%2C+H%C3%B6rtnagl+H%2C+Druml+W&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F1832407&amp;rft.issue=4&amp;rft.jtitle=Gastroenterology&amp;rft.pages=1060-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=101" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation journal">Moore K, Ward PS, Taylor GW, Williams R (1991). "Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome". <i>Gastroenterology</i> <b>100</b> (4): 1069–77. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2001805">2001805</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Systemic+and+renal+production+of+thromboxane+A2+and+prostacyclin+in+decompensated+liver+disease+and+hepatorenal+syndrome&amp;rft.aulast=Moore+K%2C+Ward+PS%2C+Taylor+GW%2C+Williams+R&amp;rft.au=Moore+K%2C+Ward+PS%2C+Taylor+GW%2C+Williams+R&amp;rft.date=1991&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F2001805&amp;rft.issue=4&amp;rft.jtitle=Gastroenterology&amp;rft.pages=1069-77&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=100" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid11910344-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid11910344_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid11910344_17-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Moreau R, Durand F, Poynard T, Duhamel C, Cervoni JP, Ichaï P, Abergel A, Halimi C, Pauwels M, Bronowicki JP, Giostra E, Fleurot C, Gurnot D, Nouel O, Renard P, Rivoal M, Blanc P, Coumaros D, Ducloux S, Levy S, Pariente A, Perarnau JM, Roche J, Scribe-Outtas M, Valla D, Bernard B, Samuel D, Butel J, Hadengue A, Platek A, Lebrec D, Cadranel JF (April 2002). "Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study". <i>Gastroenterology</i> <b>122</b> (4): 923–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fgast.2002.32364">10.1053/gast.2002.32364</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11910344">11910344</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Terlipressin+in+patients+with+cirrhosis+and+type+1+hepatorenal+syndrome%3A+a+retrospective+multicenter+study&amp;rft.aulast=Moreau+R%2C+Durand+F%2C+Poynard+T%2C+Duhamel+C%2C+Cervoni+JP%2C+Icha%C3%AF+P%2C+Abergel+A%2C+Halimi+C%2C+Pauwels+M%2C+Bronowicki+JP%2C+Giostra+E%2C+Fleurot+C%2C+Gurnot+D%2C+Nouel+O%2C+Renard+P%2C+Rivoal+M%2C+Blanc+P%2C+Coumaros+D%2C+Ducloux+S%2C+Levy+S%2C+Pariente+A%2C+Perarnau+JM%2C+Roche+J%2C+Scribe-Outtas+M%2C+Valla+D%2C+Bernard+B%2C+Samuel+D%2C+Butel+J%2C+Hadengue+A%2C+Platek+A%2C+Lebrec+D%2C+Cadranel+JF&amp;rft.au=Moreau+R%2C+Durand+F%2C+Poynard+T%2C+Duhamel+C%2C+Cervoni+JP%2C+Icha%C3%AF+P%2C+Abergel+A%2C+Halimi+C%2C+Pauwels+M%2C+Bronowicki+JP%2C+Giostra+E%2C+Fleurot+C%2C+Gurnot+D%2C+Nouel+O%2C+Renard+P%2C+Rivoal+M%2C+Blanc+P%2C+Coumaros+D%2C+Ducloux+S%2C+Levy+S%2C+Pariente+A%2C+Perarnau+JM%2C+Roche+J%2C+Scribe-Outtas+M%2C+Valla+D%2C+Bernard+B%2C+Samuel+D%2C+Butel+J%2C+Hadengue+A%2C+Platek+A%2C+Lebrec+D%2C+Cadranel+JF&amp;rft.date=April+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fgast.2002.32364&amp;rft_id=info%3Apmid%2F11910344&amp;rft.issue=4&amp;rft.jtitle=Gastroenterology&amp;rft.pages=923-30&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=122" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Kaffy F, Borderie C, Chagneau C et al. (January 1999). "Octreotide in the treatment of the hepatorenal syndrome in cirrhotic patients". <i>J. Hepatol.</i> <b>30</b> (1): 174. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0168-8278%2899%2980025-7">10.1016/S0168-8278(99)80025-7</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9927168">9927168</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Octreotide+in+the+treatment+of+the+hepatorenal+syndrome+in+cirrhotic+patients&amp;rft.au=Kaffy+F%2C+Borderie+C%2C+Chagneau+C&amp;rft.aulast=Kaffy+F%2C+Borderie+C%2C+Chagneau+C&amp;rft.date=January+1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0168-8278%2899%2980025-7&amp;rft_id=info%3Apmid%2F9927168&amp;rft.issue=1&amp;rft.jtitle=J.+Hepatol.&amp;rft.pages=174&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><span class="citation journal">Velamati PG, Herlong HF (2006). "Treatment of refractory ascites". <i>Curr Treat Options Gastroenterol</i> <b>9</b> (6): 530–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs11938-006-0009-4">10.1007/s11938-006-0009-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17081486">17081486</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Treatment+of+refractory+ascites&amp;rft.aulast=Velamati+PG%2C+Herlong+HF&amp;rft.au=Velamati+PG%2C+Herlong+HF&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs11938-006-0009-4&amp;rft_id=info%3Apmid%2F17081486&amp;rft.issue=6&amp;rft.jtitle=Curr+Treat+Options+Gastroenterol&amp;rft.pages=530-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Sherlock-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-Sherlock_20-0">^</a></b></span> <span class="reference-text"><span class="citation book">Sherlock, Sheila; James Dooley (2002). "Chapter 9". <i>Diseases of the liver and biliary system</i>. edition 11. <a href="/wiki/Wiley-Blackwell" title="Wiley-Blackwell">Wiley-Blackwell</a>. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/978-0-632-05582-1" title="Special:BookSources/978-0-632-05582-1">978-0-632-05582-1</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Chapter+9&amp;rft.aufirst=Sheila&amp;rft.au=James+Dooley&amp;rft.aulast=Sherlock&amp;rft.au=Sherlock%2C+Sheila&amp;rft.btitle=Diseases+of+the+liver+and+biliary+system&amp;rft.date=2002&amp;rft.genre=bookitem&amp;rft.isbn=978-0-632-05582-1&amp;rft.pub=Wiley-Blackwell&amp;rft.series=edition+11&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid10432325-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid10432325_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sort P, Navasa M, Arroyo V et al. (1999). <a rel="nofollow" class="external text" href="http://content.nejm.org/cgi/content/full/341/6/403">"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis"</a>. <i>N. Engl. J. Med.</i> <b>341</b> (6): 403–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM199908053410603">10.1056/NEJM199908053410603</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10432325">10432325</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Effect+of+intravenous+albumin+on+renal+impairment+and+mortality+in+patients+with+cirrhosis+and+spontaneous+bacterial+peritonitis&amp;rft.aulast=Sort+P%2C+Navasa+M%2C+Arroyo+V&amp;rft.au=Sort+P%2C+Navasa+M%2C+Arroyo+V&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcontent.nejm.org%2Fcgi%2Fcontent%2Ffull%2F341%2F6%2F403&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM199908053410603&amp;rft_id=info%3Apmid%2F10432325&amp;rft.issue=6&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=403-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=341" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-FloWo-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-FloWo_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FloWo_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-FloWo_22-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Wong F, Blendis L (2001). "New challenge of hepatorenal syndrome: prevention and treatment". <i>Hepatology</i> <b>34</b> (6): 1242–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fjhep.2001.29200">10.1053/jhep.2001.29200</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11732014">11732014</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=New+challenge+of+hepatorenal+syndrome%3A+prevention+and+treatment&amp;rft.aulast=Wong+F%2C+Blendis+L&amp;rft.au=Wong+F%2C+Blendis+L&amp;rft.date=2001&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fjhep.2001.29200&amp;rft_id=info%3Apmid%2F11732014&amp;rft.issue=6&amp;rft.jtitle=Hepatology&amp;rft.pages=1242-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=34" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Xu-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-Xu_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Xu_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Xu_23-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Xu X, Ling Q, Zhang M et al. (May 2009). "Outcome of patients with hepatorenal syndrome type 1 after liver transplantation: Hangzhou experience". <i>Transplantation</i> <b>87</b> (10): 1514–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1097%2FTP.0b013e3181a4430b">10.1097/TP.0b013e3181a4430b</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19461488">19461488</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Outcome+of+patients+with+hepatorenal+syndrome+type+1+after+liver+transplantation%3A+Hangzhou+experience&amp;rft.aulast=Xu+X%2C+Ling+Q%2C+Zhang+M&amp;rft.au=Xu+X%2C+Ling+Q%2C+Zhang+M&amp;rft.date=May+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FTP.0b013e3181a4430b&amp;rft_id=info%3Apmid%2F19461488&amp;rft.issue=10&amp;rft.jtitle=Transplantation&amp;rft.pages=1514-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=87" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Guevara-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-Guevara_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Guevara_24-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Guevara_24-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Guevara M, Ginès P, Fernández-Esparrach G et al. (1998). "Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion". <i>Hepatology</i> <b>27</b> (1): 35–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fhep.510270107">10.1002/hep.510270107</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9425914">9425914</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Reversibility+of+hepatorenal+syndrome+by+prolonged+administration+of+ornipressin+and+plasma+volume+expansion&amp;rft.au=Guevara+M%2C+Gin%C3%A8s+P%2C+Fern%C3%A1ndez-Esparrach+G&amp;rft.aulast=Guevara+M%2C+Gin%C3%A8s+P%2C+Fern%C3%A1ndez-Esparrach+G&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.510270107&amp;rft_id=info%3Apmid%2F9425914&amp;rft.issue=1&amp;rft.jtitle=Hepatology&amp;rft.pages=35-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Terli-25"><span class="mw-cite-backlink">^ <a href="#cite_ref-Terli_25-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Terli_25-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ortega R, Ginès P, Uriz J et al. (2002). "Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study". <i>Hepatology</i> <b>36</b> (4 Pt 1): 941–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fjhep.2002.35819">10.1053/jhep.2002.35819</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12297842">12297842</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Terlipressin+therapy+with+and+without+albumin+for+patients+with+hepatorenal+syndrome%3A+results+of+a+prospective%2C+nonrandomized+study&amp;rft.aulast=Ortega+R%2C+Gin%C3%A8s+P%2C+Uriz+J&amp;rft.au=Ortega+R%2C+Gin%C3%A8s+P%2C+Uriz+J&amp;rft.date=2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fjhep.2002.35819&amp;rft_id=info%3Apmid%2F12297842&amp;rft.issue=4+Pt+1&amp;rft.jtitle=Hepatology&amp;rft.pages=941-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=36" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-pmid15084697-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15084697_26-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ginès P, Cárdenas A, Arroyo V, Rodés J (2004). "Management of cirrhosis and ascites". <i>N. Engl. J. Med.</i> <b>350</b> (16): 1646–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJMra035021">10.1056/NEJMra035021</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15084697">15084697</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Management+of+cirrhosis+and+ascites&amp;rft.au=Gin%C3%A8s+P%2C+C%C3%A1rdenas+A%2C+Arroyo+V%2C+Rod%C3%A9s+J&amp;rft.aulast=Gin%C3%A8s+P%2C+C%C3%A1rdenas+A%2C+Arroyo+V%2C+Rod%C3%A9s+J&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra035021&amp;rft_id=info%3Apmid%2F15084697&amp;rft.issue=16&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1646-54&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=350" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><span class="citation journal">Martín-Llahí M, Pépin MN, Guevara M et al. (May 2008). "Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study". <i>Gastroenterology</i> <b>134</b> (5): 1352–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fj.gastro.2008.02.024">10.1053/j.gastro.2008.02.024</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18471512">18471512</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Terlipressin+and+albumin+vs+albumin+in+patients+with+cirrhosis+and+hepatorenal+syndrome%3A+a+randomized+study&amp;rft.aulast=Mart%C3%ADn-Llah%C3%AD+M%2C+P%C3%A9pin+MN%2C+Guevara+M&amp;rft.au=Mart%C3%ADn-Llah%C3%AD+M%2C+P%C3%A9pin+MN%2C+Guevara+M&amp;rft.date=May+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fj.gastro.2008.02.024&amp;rft_id=info%3Apmid%2F18471512&amp;rft.issue=5&amp;rft.jtitle=Gastroenterology&amp;rft.pages=1352-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=134" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><span class="citation journal">Pomier-Layrargues G, Paquin SC, Hassoun Z, Lafortune M, Tran A (2003). "Octreotide in hepatorenal syndrome: a randomized, double-blind, placebo-controlled, crossover study". <i>Hepatology</i> <b>38</b> (1): 238–43. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fjhep.2003.50276">10.1053/jhep.2003.50276</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12830007">12830007</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Octreotide+in+hepatorenal+syndrome%3A+a+randomized%2C+double-blind%2C+placebo-controlled%2C+crossover+study&amp;rft.aulast=Pomier-Layrargues+G%2C+Paquin+SC%2C+Hassoun+Z%2C+Lafortune+M%2C+Tran+A&amp;rft.au=Pomier-Layrargues+G%2C+Paquin+SC%2C+Hassoun+Z%2C+Lafortune+M%2C+Tran+A&amp;rft.date=2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Fjhep.2003.50276&amp;rft_id=info%3Apmid%2F12830007&amp;rft.issue=1&amp;rft.jtitle=Hepatology&amp;rft.pages=238-43&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=38" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Angeli-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-Angeli_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Angeli P, Volpin R, Gerunda G et al. (1999). "Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide". <i>Hepatology</i> <b>29</b> (6): 1690–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fhep.510290629">10.1002/hep.510290629</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10347109">10347109</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Reversal+of+type+1+hepatorenal+syndrome+with+the+administration+of+midodrine+and+octreotide&amp;rft.au=Angeli+P%2C+Volpin+R%2C+Gerunda+G&amp;rft.aulast=Angeli+P%2C+Volpin+R%2C+Gerunda+G&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.510290629&amp;rft_id=info%3Apmid%2F10347109&amp;rft.issue=6&amp;rft.jtitle=Hepatology&amp;rft.pages=1690-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=29" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-pmid17235705-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17235705_30-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA (2007). "Octreotide/Midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome". <i>Dig. Dis. Sci.</i> <b>52</b> (3): 742–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1007%2Fs10620-006-9312-0">10.1007/s10620-006-9312-0</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17235705">17235705</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Octreotide%2FMidodrine+therapy+significantly+improves+renal+function+and+30-day+survival+in+patients+with+type+1+hepatorenal+syndrome&amp;rft.au=Esrailian+E%2C+Pantangco+ER%2C+Kyulo+NL%2C+Hu+KQ%2C+Runyon+BA&amp;rft.aulast=Esrailian+E%2C+Pantangco+ER%2C+Kyulo+NL%2C+Hu+KQ%2C+Runyon+BA&amp;rft.date=2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1007%2Fs10620-006-9312-0&amp;rft_id=info%3Apmid%2F17235705&amp;rft.issue=3&amp;rft.jtitle=Dig.+Dis.+Sci.&amp;rft.pages=742-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=52" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation journal">Gülberg V, Bilzer M, Gerbes AL (1999). "Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine". <i>Hepatology</i> <b>30</b> (4): 870–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fhep.510300430">10.1002/hep.510300430</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10498636">10498636</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Long-term+therapy+and+retreatment+of+hepatorenal+syndrome+type+1+with+ornipressin+and+dopamine&amp;rft.au=G%C3%BClberg+V%2C+Bilzer+M%2C+Gerbes+AL&amp;rft.aulast=G%C3%BClberg+V%2C+Bilzer+M%2C+Gerbes+AL&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.510300430&amp;rft_id=info%3Apmid%2F10498636&amp;rft.issue=4&amp;rft.jtitle=Hepatology&amp;rft.pages=870-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><span class="citation journal">Tandon P, Bain VG, Tsuyuki RT, Klarenbach S (May 2007). "Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials". <i>Aliment. Pharmacol. Ther.</i> <b>25</b> (9): 1017–28. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1365-2036.2007.03303.x">10.1111/j.1365-2036.2007.03303.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17439502">17439502</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Systematic+review%3A+renal+and+other+clinically+relevant+outcomes+in+hepatorenal+syndrome+trials&amp;rft.aulast=Tandon+P%2C+Bain+VG%2C+Tsuyuki+RT%2C+Klarenbach+S&amp;rft.au=Tandon+P%2C+Bain+VG%2C+Tsuyuki+RT%2C+Klarenbach+S&amp;rft.date=May+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2036.2007.03303.x&amp;rft_id=info%3Apmid%2F17439502&amp;rft.issue=9&amp;rft.jtitle=Aliment.+Pharmacol.+Ther.&amp;rft.pages=1017-28&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PTX-33"><span class="mw-cite-backlink">^ <a href="#cite_ref-PTX_33-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PTX_33-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O (2000). <a rel="nofollow" class="external text" href="http://linkinghub.elsevier.com/retrieve/pii/S0016508500511834">"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial"</a>. <i>Gastroenterology</i> <b>119</b> (6): 1637–48. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Fgast.2000.20189">10.1053/gast.2000.20189</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/11113085">11113085</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Pentoxifylline+improves+short-term+survival+in+severe+acute+alcoholic+hepatitis%3A+a+double-blind%2C+placebo-controlled+trial&amp;rft.au=Akriviadis+E%2C+Botla+R%2C+Briggs+W%2C+Han+S%2C+Reynolds+T%2C+Shakil+O&amp;rft.aulast=Akriviadis+E%2C+Botla+R%2C+Briggs+W%2C+Han+S%2C+Reynolds+T%2C+Shakil+O&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0016508500511834&amp;rft_id=info%3Adoi%2F10.1053%2Fgast.2000.20189&amp;rft_id=info%3Apmid%2F11113085&amp;rft.issue=6&amp;rft.jtitle=Gastroenterology&amp;rft.pages=1637-48&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=119" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><span class="citation journal">Holt S, Goodier D, Marley R et al. (1999). "Improvement in renal function in hepatorenal syndrome with N-acetylcysteine". <i>Lancet</i> <b>353</b> (9149): 294–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2805%2974933-3">10.1016/S0140-6736(05)74933-3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9929029">9929029</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Improvement+in+renal+function+in+hepatorenal+syndrome+with+N-acetylcysteine&amp;rft.au=Holt+S%2C+Goodier+D%2C+Marley+R&amp;rft.aulast=Holt+S%2C+Goodier+D%2C+Marley+R&amp;rft.date=1999&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2805%2974933-3&amp;rft_id=info%3Apmid%2F9929029&amp;rft.issue=9149&amp;rft.jtitle=Lancet&amp;rft.pages=294-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=353" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><span class="citation journal">Clewell JD, Walker-Renard P (1994). "Prostaglandins for the treatment of hepatorenal syndrome". <i>Ann Pharmacother</i> <b>28</b> (1): 54–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8123962">8123962</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Prostaglandins+for+the+treatment+of+hepatorenal+syndrome&amp;rft.au=Clewell+JD%2C+Walker-Renard+P&amp;rft.aulast=Clewell+JD%2C+Walker-Renard+P&amp;rft.date=1994&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F8123962&amp;rft.issue=1&amp;rft.jtitle=Ann+Pharmacother&amp;rft.pages=54-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-TIPS-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-TIPS_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-TIPS_36-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Wong F, Pantea L, Sniderman K (2004). "Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome". <i>Hepatology</i> <b>40</b> (1): 55–64. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fhep.20262">10.1002/hep.20262</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15239086">15239086</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Midodrine%2C+octreotide%2C+albumin%2C+and+TIPS+in+selected+patients+with+cirrhosis+and+type+1+hepatorenal+syndrome&amp;rft.aulast=Wong+F%2C+Pantea+L%2C+Sniderman+K&amp;rft.au=Wong+F%2C+Pantea+L%2C+Sniderman+K&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.20262&amp;rft_id=info%3Apmid%2F15239086&amp;rft.issue=1&amp;rft.jtitle=Hepatology&amp;rft.pages=55-64&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=40" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><span class="citation journal">Guevara M, Rodés J (2005). "Hepatorenal syndrome". <i>Int. J. Biochem. Cell Biol.</i> <b>37</b> (1): 22–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.biocel.2004.06.007">10.1016/j.biocel.2004.06.007</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15381144">15381144</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Hepatorenal+syndrome&amp;rft.au=Guevara+M%2C+Rod%C3%A9s+J&amp;rft.aulast=Guevara+M%2C+Rod%C3%A9s+J&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.biocel.2004.06.007&amp;rft_id=info%3Apmid%2F15381144&amp;rft.issue=1&amp;rft.jtitle=Int.+J.+Biochem.+Cell+Biol.&amp;rft.pages=22-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=37" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><span class="citation journal">Mitzner SR, Stange J, Klammt S et al. (2000). "Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial". <i>Liver Transpl.</i> <b>6</b> (3): 277–86. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1053%2Flv.2000.6355">10.1053/lv.2000.6355</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/10827226">10827226</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Improvement+of+hepatorenal+syndrome+with+extracorporeal+albumin+dialysis+MARS%3A+results+of+a+prospective%2C+randomized%2C+controlled+clinical+trial&amp;rft.aulast=Mitzner+SR%2C+Stange+J%2C+Klammt+S&amp;rft.au=Mitzner+SR%2C+Stange+J%2C+Klammt+S&amp;rft.date=2000&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1053%2Flv.2000.6355&amp;rft_id=info%3Apmid%2F10827226&amp;rft.issue=3&amp;rft.jtitle=Liver+Transpl.&amp;rft.pages=277-86&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=6" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><span class="citation journal">Witzke O, Baumann M, Patschan D et al. (2004). "Which patients benefit from hemodialysis therapy in hepatorenal syndrome?". <i>J. Gastroenterol. Hepatol.</i> <b>19</b> (12): 1369–73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1111%2Fj.1440-1746.2004.03471.x">10.1111/j.1440-1746.2004.03471.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15610310">15610310</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Which+patients+benefit+from+hemodialysis+therapy+in+hepatorenal+syndrome%3F&amp;rft.aulast=Witzke+O%2C+Baumann+M%2C+Patschan+D&amp;rft.au=Witzke+O%2C+Baumann+M%2C+Patschan+D&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1440-1746.2004.03471.x&amp;rft_id=info%3Apmid%2F15610310&amp;rft.issue=12&amp;rft.jtitle=J.+Gastroenterol.+Hepatol.&amp;rft.pages=1369-73&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=19" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><span class="citation journal">Alessandria C, Ozdogan O, Guevara M et al. (2005). "MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation". <i>Hepatology</i> <b>41</b> (6): 1282–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2Fhep.20687">10.1002/hep.20687</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15834937">15834937</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=MELD+score+and+clinical+type+predict+prognosis+in+hepatorenal+syndrome%3A+relevance+to+liver+transplantation&amp;rft.au=Alessandria+C%2C+Ozdogan+O%2C+Guevara+M&amp;rft.aulast=Alessandria+C%2C+Ozdogan+O%2C+Guevara+M&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.20687&amp;rft_id=info%3Apmid%2F15834937&amp;rft.issue=6&amp;rft.jtitle=Hepatology&amp;rft.pages=1282-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=41" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><span class="citation journal">Helwig FC, Schutz CB (1932). "A liver kidney syndrome. Clinical pathological and experimental studies". <i>Surg Gynecol Obstet</i> <b>55</b>: 570–80.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=A+liver+kidney+syndrome.+Clinical+pathological+and+experimental+studies&amp;rft.au=Helwig+FC%2C+Schutz+CB&amp;rft.aulast=Helwig+FC%2C+Schutz+CB&amp;rft.date=1932&amp;rft.genre=article&amp;rft.jtitle=Surg+Gynecol+Obstet&amp;rft.pages=570-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=55" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid13377688-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid13377688_42-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hecker R, Sherlock S (December 1956). "Electrolyte and circulatory changes in terminal liver failure". <i>Lancet</i> <b>271</b> (6953): 1121–5. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/13377688">13377688</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Electrolyte+and+circulatory+changes+in+terminal+liver+failure&amp;rft.au=Hecker+R%2C+Sherlock+S&amp;rft.aulast=Hecker+R%2C+Sherlock+S&amp;rft.date=December+1956&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F13377688&amp;rft.issue=6953&amp;rft.jtitle=Lancet&amp;rft.pages=1121-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=271" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17699328-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17699328_43-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Wadei HM, Mai ML, Ahsan N, Gonwa TA (September 2006). "Hepatorenal syndrome: pathophysiology and management". <i>Clin J Am Soc Nephrol</i> <b>1</b> (5): 1066–79. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.2215%2FCJN.01340406">10.2215/CJN.01340406</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17699328">17699328</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Hepatorenal+syndrome%3A+pathophysiology+and+management&amp;rft.aulast=Wadei+HM%2C+Mai+ML%2C+Ahsan+N%2C+Gonwa+TA&amp;rft.au=Wadei+HM%2C+Mai+ML%2C+Ahsan+N%2C+Gonwa+TA&amp;rft.date=September+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2215%2FCJN.01340406&amp;rft_id=info%3Apmid%2F17699328&amp;rft.issue=5&amp;rft.jtitle=Clin+J+Am+Soc+Nephrol&amp;rft.pages=1066-79&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><span class="citation journal">Koppel MH, Coburn JW, Mims MM, Goldstein H, Boyle JD, Rubini ME (1969). "Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease". <i>N. Engl. J. Med.</i> <b>280</b> (25): 1367–71. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1056%2FNEJM196906192802501">10.1056/NEJM196906192802501</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/4890476">4890476</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHepatorenal+syndrome&amp;rft.atitle=Transplantation+of+cadaveric+kidneys+from+patients+with+hepatorenal+syndrome.+Evidence+for+the+functional+nature+of+renal+failure+in+advanced+liver+disease&amp;rft.au=Koppel+MH%2C+Coburn+JW%2C+Mims+MM%2C+Goldstein+H%2C+Boyle+JD%2C+Rubini+ME&amp;rft.aulast=Koppel+MH%2C+Coburn+JW%2C+Mims+MM%2C+Goldstein+H%2C+Boyle+JD%2C+Rubini+ME&amp;rft.date=1969&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM196906192802501&amp;rft_id=info%3Apmid%2F4890476&amp;rft.issue=25&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.pages=1367-71&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=280" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Digestive_system_diseases" title="Template:Digestive system diseases"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Digestive_system_diseases" title="Template talk:Digestive system diseases"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Digestive_system_diseases&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Diseases of the <a href="/wiki/Digestive_system" title="Digestive system" class="mw-redirect">digestive system</a> (primarily <a href="/wiki/ICD-10_Chapter_XI:_Diseases_of_the_digestive_system" title="ICD-10 Chapter XI: Diseases of the digestive system">K20–K93</a>, <a href="/wiki/List_of_ICD-9_codes_520%E2%80%93579:_diseases_of_the_digestive_system#Diseases_of_esophagus.2C_stomach.2C_and_duodenum_.28530.E2.80.93537.29" title="List of ICD-9 codes 520–579: diseases of the digestive system">530–579</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Upper_alimentary_tract#Upper_gastrointestinal_tract" title="Upper alimentary tract" class="mw-redirect">Upper GI tract</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Esophageal_disease" title="Esophageal disease">Esophagus</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Esophagitis" title="Esophagitis">Esophagitis</a>
<ul>
<li><a href="/wiki/Esophageal_candidiasis" title="Esophageal candidiasis">Candidal</a></li>
<li><a href="/wiki/Eosinophilic_esophagitis" title="Eosinophilic esophagitis">Eosinophilic</a></li>
<li><a href="/wiki/Herpetiform_esophagitis" title="Herpetiform esophagitis" class="mw-redirect">Herpetiform</a></li>
</ul>
</li>
<li><i>Rupture</i>
<ul>
<li><a href="/wiki/Boerhaave_syndrome" title="Boerhaave syndrome">Boerhaave syndrome</a></li>
<li><a href="/wiki/Mallory-Weiss_syndrome" title="Mallory-Weiss syndrome" class="mw-redirect">Mallory-Weiss syndrome</a></li>
</ul>
</li>
<li><a href="/wiki/Upper_esophageal_sphincter" title="Upper esophageal sphincter" class="mw-redirect">UES</a>
<ul>
<li><a href="/wiki/Zenker%27s_diverticulum" title="Zenker's diverticulum">Zenker's diverticulum</a></li>
</ul>
</li>
<li><a href="/wiki/Lower_esophageal_sphincter" title="Lower esophageal sphincter" class="mw-redirect">LES</a>
<ul>
<li><a href="/wiki/Barrett%27s_esophagus" title="Barrett's esophagus">Barrett's esophagus</a></li>
</ul>
</li>
<li><a href="/wiki/Esophageal_motility_disorder" title="Esophageal motility disorder">Esophageal motility disorder</a>
<ul>
<li><a href="/wiki/Nutcracker_esophagus" title="Nutcracker esophagus">Nutcracker esophagus</a></li>
<li><a href="/wiki/Achalasia" title="Achalasia">Achalasia</a></li>
<li><a href="/wiki/Diffuse_esophageal_spasm" title="Diffuse esophageal spasm">Diffuse esophageal spasm</a></li>
<li><a href="/wiki/Gastroesophageal_reflux_disease" title="Gastroesophageal reflux disease">Gastroesophageal reflux disease</a> (GERD)</li>
</ul>
</li>
<li><a href="/wiki/Laryngopharyngeal_reflux" title="Laryngopharyngeal reflux">Laryngopharyngeal reflux</a> (LPR)</li>
<li><a href="/wiki/Esophageal_stricture" title="Esophageal stricture">Esophageal stricture</a></li>
<li><a href="/wiki/Megaesophagus" title="Megaesophagus">Megaesophagus</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Stomach_disease" title="Stomach disease">Stomach</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Gastritis" title="Gastritis">Gastritis</a>
<ul>
<li><a href="/wiki/Atrophic_gastritis" title="Atrophic gastritis">Atrophic</a></li>
<li><a href="/wiki/M%C3%A9n%C3%A9trier%27s_disease" title="Ménétrier's disease">Ménétrier's disease</a></li>
<li><a href="/wiki/Gastroenteritis" title="Gastroenteritis">Gastroenteritis</a></li>
</ul>
</li>
<li><a href="/wiki/Peptic_ulcer" title="Peptic ulcer">Peptic (gastric) ulcer</a>
<ul>
<li><a href="/wiki/Cushing_ulcer" title="Cushing ulcer">Cushing ulcer</a></li>
<li><a href="/wiki/Dieulafoy%27s_lesion" title="Dieulafoy's lesion">Dieulafoy's lesion</a></li>
</ul>
</li>
<li><a href="/wiki/Dyspepsia" title="Dyspepsia" class="mw-redirect">Dyspepsia</a></li>
<li><a href="/wiki/Pyloric_stenosis" title="Pyloric stenosis">Pyloric stenosis</a></li>
<li><a href="/wiki/Achlorhydria" title="Achlorhydria">Achlorhydria</a></li>
<li><a href="/wiki/Gastroparesis" title="Gastroparesis">Gastroparesis</a></li>
<li><a href="/wiki/Gastroptosis" title="Gastroptosis">Gastroptosis</a></li>
<li><a href="/wiki/Portal_hypertensive_gastropathy" title="Portal hypertensive gastropathy">Portal hypertensive gastropathy</a></li>
<li><a href="/wiki/Gastric_antral_vascular_ectasia" title="Gastric antral vascular ectasia">Gastric antral vascular ectasia</a></li>
<li><a href="/wiki/Gastric_dumping_syndrome" title="Gastric dumping syndrome">Gastric dumping syndrome</a></li>
<li><a href="/wiki/Gastric_volvulus" title="Gastric volvulus">Gastric volvulus</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Human_gastrointestinal_tract#Lower_gastrointestinal_tract" title="Human gastrointestinal tract">Lower GI tract</a>:<br />
<a href="/wiki/Intestinal_disease" title="Intestinal disease" class="mw-redirect">Intestinal</a>/<br />
<a href="/wiki/Enteropathy" title="Enteropathy">Enteropathy</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Small_intestine" title="Small intestine">Small intestine</a><br />
(<a href="/wiki/Duodenum" title="Duodenum">Duodenum</a>/<a href="/wiki/Jejunum" title="Jejunum">Jejunum</a>/<a href="/wiki/Ileum" title="Ileum">Ileum</a>)</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Enteritis" title="Enteritis">Enteritis</a>
<ul>
<li><a href="/wiki/Duodenitis" title="Duodenitis">Duodenitis</a></li>
<li><a href="/wiki/Jejunitis" title="Jejunitis" class="mw-redirect">Jejunitis</a></li>
<li><a href="/wiki/Ileitis" title="Ileitis">Ileitis</a></li>
</ul>
</li>
<li><a href="/wiki/Peptic_ulcer" title="Peptic ulcer">Peptic (duodenal) ulcer</a>
<ul>
<li><a href="/wiki/Curling%27s_ulcer" title="Curling's ulcer">Curling's ulcer</a></li>
</ul>
</li>
<li><a href="/wiki/Malabsorption" title="Malabsorption">Malabsorption</a>: <a href="/wiki/Coeliac_disease" title="Coeliac disease">Coeliac</a></li>
<li><a href="/wiki/Tropical_sprue" title="Tropical sprue">Tropical sprue</a></li>
<li><a href="/wiki/Blind_loop_syndrome" title="Blind loop syndrome">Blind loop syndrome</a></li>
<li><a href="/wiki/Small_bowel_bacterial_overgrowth_syndrome" title="Small bowel bacterial overgrowth syndrome" class="mw-redirect">Small bowel bacterial overgrowth syndrome</a></li>
<li><a href="/wiki/Whipple%27s_disease" title="Whipple's disease">Whipple's</a></li>
<li><a href="/wiki/Short_bowel_syndrome" title="Short bowel syndrome">Short bowel syndrome</a></li>
<li><a href="/wiki/Steatorrhea" title="Steatorrhea">Steatorrhea</a></li>
<li><a href="/wiki/Milroy_disease" title="Milroy disease" class="mw-redirect">Milroy disease</a></li>
<li><a href="/wiki/Bile_acid_malabsorption" title="Bile acid malabsorption">bile acid malabsorption</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Large_intestine" title="Large intestine">Large intestine</a><br />
(<a href="/wiki/Vermiform_appendix" title="Vermiform appendix" class="mw-redirect">Appendix</a>/<a href="/wiki/Colon_(anatomy)" title="Colon (anatomy)" class="mw-redirect">Colon</a>)</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Appendicitis" title="Appendicitis">Appendicitis</a></li>
<li><a href="/wiki/Colitis" title="Colitis">Colitis</a>
<ul>
<li><a href="/wiki/Pseudomembranous_colitis" title="Pseudomembranous colitis" class="mw-redirect">Pseudomembranous</a></li>
<li><a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">Ulcerative</a></li>
<li><a href="/wiki/Ischemic_colitis" title="Ischemic colitis">Ischemic</a></li>
<li><a href="/wiki/Microscopic_colitis" title="Microscopic colitis">Microscopic</a></li>
<li><a href="/wiki/Collagenous_colitis" title="Collagenous colitis">Collagenous</a></li>
<li><a href="/wiki/Lymphocytic_colitis" title="Lymphocytic colitis">Lymphocytic</a></li>
</ul>
</li>
<li><a href="/wiki/Functional_colonic_disease" title="Functional colonic disease" class="mw-redirect">Functional colonic disease</a>
<ul>
<li><a href="/wiki/Irritable_bowel_syndrome" title="Irritable bowel syndrome">IBS</a></li>
<li><a href="/wiki/Intestinal_pseudoobstruction" title="Intestinal pseudoobstruction">Intestinal pseudoobstruction</a>&#160;/ <a href="/wiki/Ogilvie_syndrome" title="Ogilvie syndrome">Ogilvie syndrome</a></li>
</ul>
</li>
<li><a href="/wiki/Megacolon" title="Megacolon">Megacolon</a>&#160;/ <a href="/wiki/Toxic_megacolon" title="Toxic megacolon">Toxic megacolon</a></li>
<li><a href="/wiki/Diverticulitis" title="Diverticulitis">Diverticulitis</a>/<a href="/wiki/Diverticulosis" title="Diverticulosis">Diverticulosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Large and/or small</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Enterocolitis" title="Enterocolitis">Enterocolitis</a>
<ul>
<li><a href="/wiki/Necrotizing_enterocolitis" title="Necrotizing enterocolitis">Necrotizing</a></li>
</ul>
</li>
<li><a href="/wiki/Gastroenterocolitis" title="Gastroenterocolitis">Gastroenterocolitis</a></li>
<li><a href="/wiki/Inflammatory_bowel_disease" title="Inflammatory bowel disease">IBD</a>
<ul>
<li><a href="/wiki/Crohn%27s_disease" title="Crohn's disease">Crohn's disease</a></li>
</ul>
</li>
<li><i><a href="/wiki/Vascular_disease" title="Vascular disease">Vascular</a></i>: <a href="/wiki/Abdominal_angina" title="Abdominal angina">Abdominal angina</a></li>
<li><a href="/wiki/Mesenteric_ischemia" title="Mesenteric ischemia">Mesenteric ischemia</a></li>
<li><a href="/wiki/Angiodysplasia" title="Angiodysplasia">Angiodysplasia</a></li>
<li><a href="/wiki/Bowel_obstruction" title="Bowel obstruction">Bowel obstruction</a>: <a href="/wiki/Ileus" title="Ileus">Ileus</a></li>
<li><a href="/wiki/Intussusception_(medical_disorder)" title="Intussusception (medical disorder)">Intussusception</a></li>
<li><a href="/wiki/Volvulus" title="Volvulus">Volvulus</a></li>
<li><a href="/wiki/Fecal_impaction" title="Fecal impaction">Fecal impaction</a></li>
<li><a href="/wiki/Constipation" title="Constipation">Constipation</a></li>
<li><a href="/wiki/Diarrhea" title="Diarrhea">Diarrhea</a>
<ul>
<li><a href="/wiki/Infectious_diarrhea" title="Infectious diarrhea" class="mw-redirect">Infectious</a></li>
</ul>
</li>
<li><a href="/wiki/Adhesion_(medicine)" title="Adhesion (medicine)">Intestinal adhesions</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Rectum" title="Rectum">Rectum</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Proctitis" title="Proctitis">Proctitis</a>
<ul>
<li><a href="/wiki/Radiation_proctitis" title="Radiation proctitis">Radiation proctitis</a></li>
</ul>
</li>
<li><a href="/wiki/Proctalgia_fugax" title="Proctalgia fugax">Proctalgia fugax</a></li>
<li><a href="/wiki/Rectal_prolapse" title="Rectal prolapse">Rectal prolapse</a></li>
<li><a href="/wiki/Anismus" title="Anismus">Anismus</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Anal_canal" title="Anal canal">Anal canal</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Anal_fissure" title="Anal fissure">Anal fissure</a>/<a href="/wiki/Anal_fistula" title="Anal fistula">Anal fistula</a></li>
<li><a href="/wiki/Anal_abscess" title="Anal abscess" class="mw-redirect">Anal abscess</a></li>
<li><a href="/wiki/Anal_dysplasia" title="Anal dysplasia">Anal dysplasia</a></li>
<li><a href="/wiki/Pruritus_ani" title="Pruritus ani">Pruritus ani</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Gastrointestinal_bleeding" title="Gastrointestinal bleeding">GI bleeding</a>/<a href="/wiki/Blood_in_stool" title="Blood in stool">BIS</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Upper_gastrointestinal_bleeding" title="Upper gastrointestinal bleeding">Upper</a>
<ul>
<li><a href="/wiki/Hematemesis" title="Hematemesis">Hematemesis</a></li>
<li><a href="/wiki/Melena" title="Melena">Melena</a></li>
</ul>
</li>
<li><a href="/wiki/Lower_gastrointestinal_bleeding" title="Lower gastrointestinal bleeding">Lower</a>
<ul>
<li><a href="/wiki/Hematochezia" title="Hematochezia">Hematochezia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Accessory_digestive_gland" title="Accessory digestive gland" class="mw-redirect">Accessory</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Liver_disease" title="Liver disease">Liver</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Hepatitis" title="Hepatitis">Hepatitis</a>
<ul>
<li><a href="/wiki/Viral_hepatitis" title="Viral hepatitis">Viral hepatitis</a></li>
<li><a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a></li>
<li><a href="/wiki/Alcoholic_hepatitis" title="Alcoholic hepatitis">Alcoholic hepatitis</a></li>
</ul>
</li>
<li><a href="/wiki/Cirrhosis" title="Cirrhosis">Cirrhosis</a>
<ul>
<li><a href="/wiki/Primary_biliary_cirrhosis" title="Primary biliary cirrhosis">PBC</a></li>
</ul>
</li>
<li><a href="/wiki/Fatty_liver" title="Fatty liver">Fatty liver</a>
<ul>
<li><a href="/wiki/Non-alcoholic_fatty_liver_disease" title="Non-alcoholic fatty liver disease">NASH</a></li>
</ul>
</li>
<li><i><a href="/wiki/Vascular_disease" title="Vascular disease">Vascular</a></i>
<ul>
<li><a href="/wiki/Budd-Chiari_syndrome" title="Budd-Chiari syndrome" class="mw-redirect">Budd-Chiari syndrome</a></li>
<li><a href="/wiki/Hepatic_veno-occlusive_disease" title="Hepatic veno-occlusive disease">Hepatic veno-occlusive disease</a></li>
<li><a href="/wiki/Portal_hypertension" title="Portal hypertension">Portal hypertension</a></li>
<li><a href="/wiki/Nutmeg_liver" title="Nutmeg liver" class="mw-redirect">Nutmeg liver</a></li>
</ul>
</li>
<li><a href="/wiki/Alcoholic_liver_disease" title="Alcoholic liver disease">Alcoholic liver disease</a></li>
<li><a href="/wiki/Liver_failure" title="Liver failure">Liver failure</a>
<ul>
<li><a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">Hepatic encephalopathy</a></li>
<li><a href="/wiki/Acute_liver_failure" title="Acute liver failure">Acute liver failure</a></li>
</ul>
</li>
<li><a href="/wiki/Liver_abscess" title="Liver abscess">Liver abscess</a>
<ul>
<li><a href="/wiki/Pyogenic_liver_abscess" title="Pyogenic liver abscess">Pyogenic</a></li>
<li><a href="/wiki/Amoebic_liver_abscess" title="Amoebic liver abscess">Amoebic</a></li>
</ul>
</li>
<li><strong class="selflink">Hepatorenal syndrome</strong></li>
<li><a href="/wiki/Peliosis_hepatis" title="Peliosis hepatis">Peliosis hepatis</a></li>
<li><a href="/wiki/Metabolic_disorders" title="Metabolic disorders">Metabolic disorders</a>
<ul>
<li><a href="/wiki/Wilson%27s_Disease" title="Wilson's Disease" class="mw-redirect">Wilson's Disease</a></li>
<li><a href="/wiki/Hemochromatosis" title="Hemochromatosis" class="mw-redirect">Hemochromatosis</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Gallbladder_disease" title="Gallbladder disease">Gallbladder</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cholecystitis" title="Cholecystitis">Cholecystitis</a></li>
<li><a href="/wiki/Gallstone" title="Gallstone">Gallstones</a>/<a href="/wiki/Cholecystolithiasis" title="Cholecystolithiasis" class="mw-redirect">Cholecystolithiasis</a></li>
<li><a href="/wiki/Cholesterolosis_of_gallbladder" title="Cholesterolosis of gallbladder">Cholesterolosis</a></li>
<li><a href="/wiki/Rokitansky-Aschoff_sinuses" title="Rokitansky-Aschoff sinuses" class="mw-redirect">Rokitansky-Aschoff sinuses</a></li>
<li><a href="/wiki/Postcholecystectomy_syndrome" title="Postcholecystectomy syndrome">Postcholecystectomy syndrome</a></li>
<li><a href="/wiki/Porcelain_gallbladder" title="Porcelain gallbladder">Porcelain gallbladder</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Bile_duct" title="Bile duct">Bile duct</a>/<br />
Other <a href="/wiki/Biliary_tree" title="Biliary tree" class="mw-redirect">biliary tree</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Cholangitis" title="Cholangitis" class="mw-redirect">Cholangitis</a>
<ul>
<li><a href="/wiki/Primary_sclerosing_cholangitis" title="Primary sclerosing cholangitis">PSC</a></li>
<li><a href="/wiki/Secondary_sclerosing_cholangitis" title="Secondary sclerosing cholangitis">Secondary sclerosing cholangitis</a></li>
<li><a href="/wiki/Ascending_cholangitis" title="Ascending cholangitis">Ascending</a></li>
</ul>
</li>
<li><a href="/wiki/Cholestasis" title="Cholestasis">Cholestasis</a>/<a href="/wiki/Mirizzi%27s_syndrome" title="Mirizzi's syndrome">Mirizzi's syndrome</a></li>
<li><a href="/wiki/Biliary_fistula" title="Biliary fistula">Biliary fistula</a></li>
<li><a href="/wiki/Haemobilia" title="Haemobilia">Haemobilia</a></li>
<li><a href="/wiki/Gallstone" title="Gallstone">Gallstones</a>/<a href="/wiki/Cholelithiasis" title="Cholelithiasis" class="mw-redirect">Cholelithiasis</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Common_bile_duct" title="Common bile duct">Common bile duct</a></i>
<ul>
<li><a href="/wiki/Choledocholithiasis" title="Choledocholithiasis" class="mw-redirect">Choledocholithiasis</a></li>
<li><a href="/wiki/Biliary_dyskinesia" title="Biliary dyskinesia">Biliary dyskinesia</a></li>
</ul>
</li>
<li><a href="/wiki/Sphincter_of_Oddi_dysfunction" title="Sphincter of Oddi dysfunction">Sphincter of Oddi dysfunction</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Pancreatic_disease" title="Pancreatic disease">Pancreatic</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pancreatitis" title="Pancreatitis">Pancreatitis</a>
<ul>
<li><a href="/wiki/Acute_pancreatitis" title="Acute pancreatitis">Acute</a></li>
<li><a href="/wiki/Chronic_pancreatitis" title="Chronic pancreatitis">Chronic</a></li>
<li><a href="/wiki/Hereditary_pancreatitis" title="Hereditary pancreatitis">Hereditary</a></li>
<li><a href="/wiki/Pancreatic_abscess" title="Pancreatic abscess">Pancreatic abscess</a></li>
</ul>
</li>
<li><a href="/wiki/Pancreatic_pseudocyst" title="Pancreatic pseudocyst">Pancreatic pseudocyst</a></li>
<li><a href="/wiki/Exocrine_pancreatic_insufficiency" title="Exocrine pancreatic insufficiency">Exocrine pancreatic insufficiency</a></li>
<li><a href="/wiki/Pancreatic_fistula" title="Pancreatic fistula">Pancreatic fistula</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Abdominopelvic_cavity" title="Abdominopelvic cavity">Abdominopelvic</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hernia" title="Hernia">Hernia</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Diaphragmatic_hernia" title="Diaphragmatic hernia">Diaphragmatic</a>
<ul>
<li><a href="/wiki/Congenital_diaphragmatic_hernia" title="Congenital diaphragmatic hernia">Congenital</a></li>
</ul>
</li>
<li><a href="/wiki/Hiatus_hernia" title="Hiatus hernia">Hiatus</a></li>
</ul>
<ul>
<li><a href="/wiki/Inguinal_hernia" title="Inguinal hernia">Inguinal</a>
<ul>
<li><a href="/wiki/Indirect_inguinal_hernia" title="Indirect inguinal hernia" class="mw-redirect">Indirect</a></li>
<li><a href="/wiki/Direct_inguinal_hernia" title="Direct inguinal hernia" class="mw-redirect">Direct</a></li>
</ul>
</li>
<li><a href="/wiki/Umbilical_hernia" title="Umbilical hernia">Umbilical</a></li>
<li><a href="/wiki/Femoral_hernia" title="Femoral hernia">Femoral</a></li>
<li><a href="/wiki/Obturator_hernia" title="Obturator hernia">Obturator</a></li>
<li><a href="/wiki/Spigelian_hernia" title="Spigelian hernia">Spigelian</a></li>
</ul>
<ul>
<li><i><a href="/wiki/Lumbar_hernia" title="Lumbar hernia" class="mw-redirect">Lumbar</a></i>
<ul>
<li><a href="/wiki/Petit%27s_hernia" title="Petit's hernia">Petit's</a></li>
<li><a href="/wiki/Grynfeltt-Lesshaft_hernia" title="Grynfeltt-Lesshaft hernia">Grynfeltt-Lesshaft</a></li>
</ul>
</li>
</ul>
<ul>
<li><i>Undefined location</i>
<ul>
<li><a href="/wiki/Incisional_hernia" title="Incisional hernia">Incisional</a></li>
<li><a href="/wiki/Internal_hernia" title="Internal hernia">Internal hernia</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Peritoneal_disease" title="Peritoneal disease" class="mw-redirect">Peritoneal</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Peritonitis" title="Peritonitis">Peritonitis</a>
<ul>
<li><a href="/wiki/Spontaneous_bacterial_peritonitis" title="Spontaneous bacterial peritonitis">Spontaneous bacterial peritonitis</a></li>
</ul>
</li>
<li><a href="/wiki/Hemoperitoneum" title="Hemoperitoneum">Hemoperitoneum</a></li>
<li><a href="/wiki/Pneumoperitoneum" title="Pneumoperitoneum">Pneumoperitoneum</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Digestive_system_navs" title="Template:Digestive system navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Digestive_system_navs" title="Template talk:Digestive system navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Digestive_system_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Digestion" title="Digestion">digestion</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Anatomy
<ul>
<li><a href="/wiki/Template:Digestive_tract" title="Template:Digestive tract">tract</a></li>
<li><a href="/wiki/Template:Accessory_digestive_glands" title="Template:Accessory digestive glands">glands</a></li>
<li><a href="/wiki/Template:Abdominopelvic_cavity" title="Template:Abdominopelvic cavity" class="mw-redirect">other</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Gastrointestinal_physiology" title="Template:Gastrointestinal physiology">Physiology</a>
<ul>
<li><a href="/wiki/Template:Digestive_enzymes" title="Template:Digestive enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Development_of_digestive_system" title="Template:Development of digestive system">Development</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Congenital_malformations_and_deformations_of_digestive_system" title="Template:Congenital malformations and deformations of digestive system">Congenital</a></li>
<li><a href="/wiki/Template:Digestive_system_neoplasia" title="Template:Digestive system neoplasia">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Crohn%27s_disease_and_ulcerative_colitis" title="Template:Crohn's disease and ulcerative colitis">Inflammatory bowel disease</a></li>
<li><a href="/wiki/Template:Gluten_sensitivity" title="Template:Gluten sensitivity">Gluten sensitivity</a></li>
<li><a href="/wiki/Template:Digestive_system_diseases" title="Template:Digestive system diseases">Other</a></li>
<li><a href="/wiki/Template:Digestive_system_and_abdomen_symptoms_and_signs" title="Template:Digestive system and abdomen symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_digestive_system_and_general_abdominal_signs" title="Template:Eponymous medical signs for digestive system and general abdominal signs">eponymous</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Clinical_biochemistry_blood_tests" title="Template:Clinical biochemistry blood tests">Blood tests</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="text-align: center;">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Digestive_system_procedures" title="Template:Digestive system procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Anabolic_steroids" title="Template:Anabolic steroids">anabolic steroids</a></li>
<li><a href="/wiki/Template:Antacids" title="Template:Antacids">antacids</a></li>
<li><a href="/wiki/Template:Antidiarrheals,_intestinal_anti-inflammatory/anti-infective_agents" title="Template:Antidiarrheals, intestinal anti-inflammatory/anti-infective agents" class="mw-redirect">diarrhoea and infection</a></li>
<li><a href="/wiki/Template:Bile_and_liver_therapy" title="Template:Bile and liver therapy">bile and liver</a></li>
<li><a href="/wiki/Template:Drugs_for_functional_gastrointestinal_disorders" title="Template:Drugs for functional gastrointestinal disorders">functional gastrointestinal disorders</a></li>
<li><a href="/wiki/Template:Laxatives" title="Template:Laxatives">laxatives</a></li>
<li><a href="/wiki/Template:Drugs_for_peptic_ulcer_and_GORD" title="Template:Drugs for peptic ulcer and GORD">peptic ulcer and reflux</a></li>
<li><a href="/wiki/Template:Antiemetics" title="Template:Antiemetics">nausea and vomiting</a></li>
<li><a href="/wiki/Template:Other_alimentary_tract_and_metabolism_products" title="Template:Other alimentary tract and metabolism products">other</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Gastrointestinal_surgery" title="Template:Gastrointestinal surgery">Surgery</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1104
CPU time usage: 0.565 seconds
Real time usage: 0.655 seconds
Preprocessor visited node count: 3763/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 172129/2097152 bytes
Template argument size: 363/2097152 bytes
Highest expansion depth: 12/40
Expensive parser function count: 1/500
Lua time usage: 0.204/10.000 seconds
Lua memory usage: 5.71 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  517.633      1 - -total
 43.86%  227.009      1 - Template:Reflist
 26.79%  138.674     42 - Template:Cite_journal
 16.51%   85.437      6 - Template:Navbox
 12.62%   65.311      1 - Template:Gastroenterology
 11.03%   57.091      1 - Template:Featured_article
 10.60%   54.872      1 - Template:Top_icon
  7.67%   39.682      1 - Template:Convert
  6.45%   33.373      1 - Template:Use_dmy_dates
  5.09%   26.325      1 - Template:Infobox
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:2204330-0!*!0!!en!4!* and timestamp 20150706211518 and revision id 649122316
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Hepatorenal_syndrome&amp;oldid=649122316">https://en.wikipedia.org/w/index.php?title=Hepatorenal_syndrome&amp;oldid=649122316</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Diseases_of_liver" title="Category:Diseases of liver">Diseases of liver</a></li><li><a href="/wiki/Category:Syndromes" title="Category:Syndromes">Syndromes</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Use_dmy_dates_from_April_2014" title="Category:Use dmy dates from April 2014">Use dmy dates from April 2014</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li><li><a href="/wiki/Category:Featured_articles" title="Category:Featured articles">Featured articles</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hepatorenal+syndrome&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hepatorenal+syndrome" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Hepatorenal_syndrome"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Hepatorenal_syndrome"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Hepatorenal_syndrome" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Hepatorenal_syndrome" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Hepatorenal_syndrome" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Hepatorenal_syndrome&amp;oldid=649122316" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Hepatorenal_syndrome&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q247131" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Hepatorenal_syndrome&amp;id=649122316" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Hepatorenal+syndrome">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Hepatorenal+syndrome&amp;oldid=649122316&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Hepatorenal_syndrome&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar badge-Q17437796 badge-featuredarticle" title="featured article"><a href="//ar.wikipedia.org/wiki/%D9%85%D8%AA%D9%84%D8%A7%D8%B2%D9%85%D8%A9_%D8%A7%D9%84%D9%83%D8%A8%D8%AF%D9%8A%D8%A9_%D8%A7%D9%84%D9%83%D9%84%D9%88%D9%8A%D8%A9" title="متلازمة الكبدية الكلوية – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-az"><a href="//az.wikipedia.org/wiki/Hepatorenal_sindrom" title="Hepatorenal sindrom – Azerbaijani" lang="az" hreflang="az">Azərbaycanca</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Hepatorenales_Syndrom" title="Hepatorenales Syndrom – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/S%C3%ADndrome_hepatorrenal" title="Síndrome hepatorrenal – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Syndrome_h%C3%A9pato-r%C3%A9nal" title="Syndrome hépato-rénal – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Sindrom_hepatorenal" title="Sindrom hepatorenal – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it badge-Q17437798 badge-goodarticle" title="good article"><a href="//it.wikipedia.org/wiki/Sindrome_epatorenale" title="Sindrome epatorenale – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Zesp%C3%B3%C5%82_w%C4%85trobowo-nerkowy" title="Zespół wątrobowo-nerkowy – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/S%C3%ADndrome_hepatorrenal" title="Síndrome hepatorrenal – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-ru"><a href="//ru.wikipedia.org/wiki/%D0%93%D0%B5%D0%BF%D0%B0%D1%82%D0%BE%D1%80%D0%B5%D0%BD%D0%B0%D0%BB%D1%8C%D0%BD%D1%8B%D0%B9_%D1%81%D0%B8%D0%BD%D0%B4%D1%80%D0%BE%D0%BC" title="Гепаторенальный синдром – Russian" lang="ru" hreflang="ru">Русский</a></li><li class="interlanguage-link interwiki-fi"><a href="//fi.wikipedia.org/wiki/Hepatorenaalinen_oireyhtym%C3%A4" title="Hepatorenaalinen oireyhtymä – Finnish" lang="fi" hreflang="fi">Suomi</a></li><li class="interlanguage-link interwiki-th badge-Q17437798 badge-goodarticle" title="good article"><a href="//th.wikipedia.org/wiki/%E0%B8%81%E0%B8%A5%E0%B8%B8%E0%B9%88%E0%B8%A1%E0%B8%AD%E0%B8%B2%E0%B8%81%E0%B8%B2%E0%B8%A3%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B9%84%E0%B8%95%E0%B9%80%E0%B8%99%E0%B8%B7%E0%B9%88%E0%B8%AD%E0%B8%87%E0%B8%88%E0%B8%B2%E0%B8%81%E0%B9%82%E0%B8%A3%E0%B8%84%E0%B8%95%E0%B8%B1%E0%B8%9A" title="กลุ่มอาการโรคไตเนื่องจากโรคตับ – Thai" lang="th" hreflang="th">ไทย</a></li><li class="interlanguage-link interwiki-zh"><a href="//zh.wikipedia.org/wiki/%E8%82%9D%E8%82%BE%E7%BB%BC%E5%90%88%E7%97%87" title="肝肾综合症 – Chinese" lang="zh" hreflang="zh">中文</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q247131#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 27 February 2015, at 18:56.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Hepatorenal_syndrome&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":110,"wgHostname":"mw1071"});
}</script>
	</body>
</html>
